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ABSTRACT 
THOMAS C. LONG: Mammalian and Bacterial Toxicity of Nanoparticles Used In 
Hazardous Waste Treatment and Environmental Remediation 
 (Under the direction of Michael D. Aitken) 
 
 The increased use of engineered nanomaterials in pharmaceuticals, materials 
science, and consumer products has raised questions regarding the potential risks of these 
nanoproducts to human and ecological health.  Environmental applications for in situ site 
remediation and water treatment can provide a route for human exposure and are 
especially appropriate for toxicity evaluation.  This research investigated the response of 
bacteria and mammalian nerve cells to commercially available zero-valent iron (ZVI) and 
TiO2 nanoparticles.  In the first part of the research, immortalized mouse microglia (BV2) 
responded to non-cytotoxic concentrations of TiO2 with a rapid and sustained release of 
reactive oxygen species (ROS) consistent with both the oxidative burst and interference 
with electron transport.  Transmission electron microscopy documented engulfment of 
aggregates of nanosized particles.  A second study found that extended exposure of 
microglia to TiO2 produced loss of nuclear staining consistent with DNA degradation. 
Gene expression analysis in microglia indicated up-regulation of inflammatory, 
apoptotic, and cell cycling pathways and down-regulation of energy metabolism 
following TiO2 exposure.  TiO2 did not produce cytotoxicity in immortalized 
dopaminergic neurons (N27), but primary cultures with mixed neuronal and glial 
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populations showed neuronal loss and microscopic evidence of neuronal apoptosis, 
indicating potential involvement of glia in neuronal cytotoxicity. 
 Experiments with Escherichia coli K-12 indicated that ZVI, but not TiO2, caused 
significant viability loss in the absence of photoactivation.  Gene expression analysis 
found that ZVI induced genes in the oxidative phosphorylyation pathway, primarily those 
associated with electron transport.  This result was corroborated by increased respiration 
following ZVI exposure, consistent with increased activity of the electron transport chain.  
Neither effect was observed after TiO2 exposure.  Electron microscopy documented 
localization of ZVI nanoparticles on the cell surface, potentially interfering with 
maintenance of the proton-motive force necessary for ATP generation.  Consistent with 
its lack of toxicity, TiO2 induced cell maintenance functions and down-regulated stress 
response pathways, and did not associate with cell membranes. Considering the results 
from all studies, it appears that ZVI and TiO2 provoke different responses in bacterial and 
mammalian cells and may act via separate modes of action. 
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1.  INTRODUCTION 
 
1.1 Background 
Engineered nanomaterials have generated a large amount of interest recently due to 
their enhanced physicochemical properties compared to the corresponding bulk phase 
materials.  Nanomaterials are defined as having one or more characteristic dimensions in the 
1-100 nm range.  Particles of this size have greatly increased surface area and much higher 
density of surface features (e.g., charge, functional groups) than larger particles, increasing 
their reactivity and catalytic activity.  This makes them particularly suitable for use in 
pollutant transformation processes in air purification, water treatment, and site remediation.  
The same properties also create the potential for biological effects in humans and other 
organisms exposed to nanoparticles. 
 Two widely used nanomaterials for treatment and remediation are zero-valent iron 
(ZVI) and TiO2.  Micron-sized particles of these materials are being replaced with nanosize 
versions to improve treatment efficiency because of their increased surface area and catalytic 
activity.  More than 20 pilot- and field-scale sites have applied nanoscale ZVI for treatment 
of chlorinated solvents (1).  It is also being tested for use in reductive treatment of arsenic 
and other metals (2, 3), polychlorinated biphenyls (4), and nitrate-containing compounds 
such as munitions (5).  As a reductant, ZVI itself is oxidized to form magnetite (Fe3O4) and 
other iron oxides, which have lower reducing power, but can still support heterogeneous 
catalysis on their surfaces.  ZVI is typically injected into the subsurface as a slurry and has 
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limited mobility, adsorbing to mineral surfaces close to the injection site at length scales of 
centimeters to meters (6). Rapid agglomeration is observed for ZVI, as with other 
nanoparticles, but the rate is enhanced due to magnetic effects (7). Efforts are underway to 
increase mobility and targeting of non-aqueous-phase contaminants by surface modification 
of ZVI with polymers and surfactants (8, 9). 
 TiO2 has been used for photocatalytic applications in combination with UV light to 
oxidize contaminants in air, drinking water, and soil (10-13). TiO2 acts as a semiconductor 
when irradiated with UV light of sufficient energy (wavelength <380 nm) to dislodge 
electrons from the crystal structure. These electrons may recombine or form reactive oxygen 
species (ROS), which participate in redox reactions with inorganic and organic pollutants 
(14, 15). Of the two primary crystalline forms of TiO2 in commercial use (anatase and rutile), 
anatase is the more photoactive. Doping of TiO2 with other elements such as nitrogen is 
being pursued to expand the photocatalytic activity into the visible range (16). Catalysis in 
the absence of light activation is greatly reduced or negligible. 
 Toxicity testing has been identified as a critical part of the development of new 
nanotechnologies (17).  A relatively small portion of the overall US research budget for 
nanotechnology is allocated to health effects research, but initial studies have been conducted 
in this area to investigate the in vitro and in vivo effects of nanoparticles.  Several researchers 
have examined the toxicity of ZVI or its oxidation product magnetite in mammalian cells, 
including liver cells and human dermal fibroblasts (18-20).  Surface coatings such as 
polyethylene glycol, polysaccharides, and chelating agents have been tested for use with 
magnetic nanoparticles in drug delivery and imaging and tend to decrease toxic effects (18, 
20-22).  Other studies have found that magnetic nanoparticles coated with dimercapto 
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succinic acid (DMSA) diminish viability and capacity of PC12 neurons to extend neurites 
(23) and exhibited weak toxicity in human dermal fibroblasts (22). TiO2 has been one of the 
most studied metal oxide nanoparticles in pulmonary research and has been considered a 
negative control in some studies due to its low relative toxicity compared to particles such as 
coal dust, silica and urban particulates (24-26).  More recent studies have found mammalian 
toxicity in lung cells and human dermal fibroblasts (27-29) and in animals (30-32).  
Inflammatory responses and stimulation of macrophages to produce ROS have been 
suggested as potential modes of action for toxicity of TiO2 and other nanoparticles (33). 
Researchers have found evidence that nanoparticles can cross biological barriers and 
translocate to other organ systems (34-37), including regions in the brain (38).  Nanoparticles 
have also been shown to cross the tight blood-brain barrier (39), of possible benefit for 
pharmaceutical applications, but creating concerns about the potential neurotoxicity of 
environmental nanoparticles.  Another reason for such concern is the tendency of 
nanoparticles to stimulate inflammatory and oxidative stress responses (40), which are of 
particular relevance to the brain due to the involvement of these processes in 
neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and amyotrophic lateral 
sclerosis (41-44).  The brain’s high consumption of energy makes it especially vulnerable to 
oxidative stress resulting from the leakage of oxygen radicals during electron transport in 
actively respiring mitochondria (45). 
The response of the brain to foreign substances is mediated by microglia, phagocytic 
cells related to macrophages found in other organ systems (46).  Microglia are activated at a 
very early stage in the brain’s injury response and act to engulf and phagocytize invading 
microorganisms as well as debris from lysed cells (47).  Activated microglia also rapidly 
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release ROS in a process known as the oxidative burst.  Overproduction of ROS through 
prolonged activation is damaging to surrounding tissue (48).  The occurrence of such 
activation in association with nanoparticle exposure is a potential mode of action for 
nanoparticle toxicity in the brain.  Another potential source of damaging ROS is escape of 
superoxide (O2.-) from the electron transport chain in mitochondria, which at low levels is 
neutralized by intracellular antioxidant mechanisms.  Interference with electron transport and 
oxidative phosphorylation can result in high levels of superoxide, which converts to other 
damaging species such as hydrogen peroxide, hydroxyl radical, and reactive nitrogen species 
(45). 
Toxic effects of metal and metal oxide nanoparticles such as MgO, ZnO, CeO2, and 
Ag have been observed in bacteria (33, 49-59), with most research to date conducted on 
silver nanoparticles. Most effects appear to be related to membrane disruption (33, 49-54). 
For example, silver nanoparticles associate with the cell membrane and cause membrane 
damage leading to leakage of cellular contents and interference with the proton-motive force 
necessary for ATP generation (54).  Other types of nanoparticles, such as fullerenes (55, 56), 
have been observed to be toxic to bacteria, and this toxicity is mitigated by surface 
derivatization.  Although photoactivated TiO2 is used in antimicrobial applications, in the 
absence of light it is less toxic to bacteria than other oxide nanoparticles (50).  No published 
reports are available on nanoscale ZVI toxicity to bacteria or other organisms in the 
environment.  The limited evidence available to date indicates that particle composition, as 
well as charge and other surface properties, affect the biological response to nanoparticles. 
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1.2 Objectives 
The objectives of this research were to investigate the toxicity and gene expression 
profiles of commercially available ZVI and TiO2 nanoparticles in bacteria and neural cells 
involved in oxidative stress.  In the first part of the research, the response of immortalized 
mouse microglia to non-cytotoxic concentrations of Degussa P25 TiO2 (P25) was evaluated 
by measuring ROS release and examining the engulfment of P25 by the cells.  
Physicochemical properties of P25 suspensions in biological buffers were measured at time 
points and concentrations relevant to the biological response.  
The second objective was to examine the possible toxicity of P25 to immortalized 
microglia and neurons as well as primary cultures of mixed glial and neuronal populations.  
Microglia were examined for DNA degradation after extended exposure to P25, and gene 
expression analysis was performed on microglia exposed to sub-lethal concentrations of P25 
to identify pathways associated with induced and repressed genes.  The effect of P25 on 
viability of immortalized neurons was measured, and primary cultures were examined for 
neuronal loss and evidence of apoptosis using immunohistochemical staining. 
The third and final objective was to investigate the potential effects of commercially 
available ZVI and TiO2 nanoparticles on bacteria.  The viability of Escherichia coli was 
determined following ZVI and TiO2 exposure, and gene expression analysis was performed 
on E. coli cultures using whole-genome microarrays following sub-lethal exposures to these 
particles.  An OS-sensitive mutant strain was used to evaluate the possible role of oxidative 
stress in toxicity.  The effect of these nanoparticles on oxygen uptake and energy metabolism 
was determined with respirometry, and the association of the particles with the cells was 
examined using both scanning and transmission electron microscopy. 
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1.3 Organization of the Dissertation 
The dissertation is organized into three main chapters, each devoted to one of the 
primary research objectives, followed by a chapter that summarizes the conclusions of the 
research.  Each of the three main chapters is a published paper or a draft manuscript intended 
for submission to a peer-reviewed journal. The summary and conclusions chapter discusses 
the relationships among the findings, reviews possible mechanisms for the observed effects, 
suggests future research, and describes the implications of the research for human health, 
environmental effects, and treatment and remediation strategies. 
Chapter 2 has previously been published (Long, T.C.; Saleh, N.; Tilton, R.D.; Lowry, 
G.V.; Veronesi, B. Environ. Sci. Technol. 2006, 40, 4346-4352).  Chapter 3 has been 
published online (Long, T.C.; Tajuba, J.; Sama, P.; Saleh, N.; Swartz, C.; Parker, J.; Lowry, 
G.V.; Veronesi, B. Environ. Health Perspect. 2007, doi:10.1289/ehp.10216).  Chapter 4 is a 
draft manuscript intended for submission to a peer-reviewed journal.  The co-authors for each 
manuscript are listed in a footnote at the beginning of the corresponding chapter.    
 
  
 
 
 
2.  TITANIUM DIOXIDE (P25) PRODUCES REACTIVE OXYGEN SPECIES IN 
IMMORTALIZED BRAIN MICROGLIA (BV2): IMPLICATIONS FOR 
NANOPARTICLE NEUROTOXICITY∗ 
 
2.1 Introduction 
The novel physical and chemical properties of engineered nanoparticles make them 
attractive for use in medical, agricultural, industrial, manufacturing and military sectors.  
Although hundreds of tons of nanoparticles enter the environment annually, little is known of 
their interactions with biological systems, and recent studies indicate that some are not 
completely benign to biological and environmental targets (60). Such reports have the 
potential to transform the focus of environmental protection. The federal government, aware 
of this possibility, has not only articulated the need for research on the environmental and 
health effects of nanotechnology (61), but is actively supporting such research (62).  Of the 
many types of nano-products in current use, toxicity testing should obviously begin with 
those that pose the highest risk of environmental exposure (17).  Nanosize titanium dioxide 
(TiO2) is a reasonable candidate for study since it is widely used in manufacturing (63, 64), in 
the environment to decontaminate air, soil and water (12, 13, 65-67), and more recently in 
consumer products (e.g. toothpastes, sunscreens, cosmetics, food products, etc.) (68, 69). 
Such widespread use and its potential entry through dermal, ingestion and inhalation routes 
suggests that nanosize TiO2 poses considerable exposure risk to humans, livestock and eco-
relevant species (e.g., fish, daphnia, nematodes, and plankton).  Although exposure to 
                                                 
∗
 Originally published as Long, T.C.; Saleh, N.; Tilton, R.D.; Lowry, G.V.; Veronesi, B. Environ. Sci. Technol. 
2006, 40, 4346-4352. 
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different TiO2 particle sizes and formulations (nanosize, pigment grade, and surface coated) 
has produced only marginal results in rodents (70-72), numerous in vitro studies report that 
TiO2 nanoparticles cause oxidative stress (OS)-mediated toxicity in diverse cell types, 
including human colon cells (73), osteoblasts (74), endothelia (75), epithelia (27), skin 
fibroblast (76), liver (19), alveolar macrophages (31, 77, 78) and Salmonella bacteria (79).  
The potential neurotoxicity of TiO2 in culture has yet to be examined.  
Several studies report that inhaled or injected nanoparticles enter systemic circulation 
(36, 37, 80) and migrate to various organs and tissues, raising concern that they may cause 
damage to biological systems through OS pathways (81).  The brain is especially vulnerable 
to OS damage, and recent studies indicate that nanosize particles can cross the blood brain 
barrier (82) and enter the central nervous system (CNS) of animals (35, 37, 38).  In the CNS, 
OS is largely mediated by the microglia, a macrophage-like, phagocytic cell that is normally 
inactive unless confronted by potentially damaging, exogenous stimuli (e.g., xenobiotics, 
chemicals, particles).  Their immediate response to such stimuli is known as the “oxidative 
burst” (83, 84) and involves a rapid sequence of events that includes an increase in metabolic 
activity, a change in cell shape and size, and cytoplasmic engulfment (i.e., phagocytosis) of 
the offending stimuli. During phagocytosis, the plasma membrane of the phagocyte 
surrounds the foreign substance, invaginates, and internalizes the membrane bound material 
(i.e., phagosome).  The signaling mechanisms for the subsequent oxidative burst are not well 
defined, but invagination of the plasma membrane appears prerequisite for the activation of    
a multi-component enzyme system known as NADPHox and the initiation of the oxidative 
burst.  This activation results in the immediate production of superoxide anions (O2.-) which 
convert to multiple reactive oxygen species (ROS) including hydrogen peroxide (H2O2), 
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hydroxyl radicals (OH.) and peroxynitrites that can destroy the offending stimuli through OS 
pathways. The excess O2.- and its dismutation product H2O2 are either retained within 
cytoplasmic granules, providing a immediate supply of intracellular oxidants or allowed to 
diffuse from the microglial plasma membrane where they can potentially damage the 
proteins, lipids, and DNA of neighboring cells, especially neurons (85, 86).  Microglia-
mediated neuronal damage through OS pathways has been proposed to underlie 
neurodegenerative diseases such as Amyotrophic Lateral Sclerosis, Parkinson’s and 
Alzheimer’s (41-43).   
Although the oxidative burst is the major source of ROS in the activated microglia, 
O2.- is also generated as a byproduct of normal mitochondrial energy production (i.e., 
bioenergetics) in the quiescent cell.  Mitochondria produce cellular energy (ATP)  by 
transferring electrons along a series of enzymatic complexes (Complex I-IV) known as the 
electron transport chain (ETC) (45).  During this transfer, single electrons escape and reduce 
molecular oxygen to O2·-.  This is the fate of approximately 1% of all oxygen consumed and 
defines the ETC as the major producer of ROS in non-phagocytic cells and tissues. Although 
the levels of O2.- generated from ETC are relatively low and efficiently neutralized by matrix-
located antioxidant enzyme systems (i.e., endogenous scavengers), the  rate of O2.- generation 
can be significantly increased if one or more of the ETC enzyme complexes is inhibited.  
   The O2.- formed by the oxidative burst or from ETC leakage is quickly reduced to  the 
more stable H2O2 by superoxide dismutase, an enzyme located in intracellular microsomes, 
peroxisomes and within the mitochondria matrix.  Although O2.- radicals can be directly 
toxic, they have limited reactivity to lipids.  However, in the presence of transition metals, 
most notably ferrous iron, superoxides can convert to the highly reactive hydroxyl radical 
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(OH.) via the Fenton reaction. The hydroxyl radical is considered the primary agent of lipid 
peroxidation.   
Several recent articles have prescribed a formal protocol for nanotoxicity testing (17, 
87) which  suggests that physicochemically described nanoparticles  should first be tested in 
cultures of relevant target cells for the production of ROS.  This is followed by toxicity 
testing in more complex cultures, in eco-relevant species and ultimately in animals. The 
present study follows this format by first measuring the ROS response of microglia (BV2) 
exposed to physicochemically characterized nano-TiO2 (Degussa P25).  Microglia were 
chosen in view of their responsiveness to xenobiotics and their pivotal role in OS-mediated 
neurodegeneration.  The BV2 is an immortalized cell line that responds to pharmaceutical 
agents, particulates, and environmental chemicals with characteristic signs of OS (88-90).  In 
the present study, BV2 were exposed to non-cytotoxic doses of P25, and the immediate and 
prolonged release of ROS was measured over a 120 min exposure period using various 
fluoroprobes.  Transmission electron microscopy (TEM) was used to document the 
phagocytic response of the microglia to P25 exposure.  Physicochemical properties of P25 
(e.g., particle size distribution, zeta potential, and dispersion stability) were measured in 
culture media and physiological buffer at time points relevant to the biological response. 
   
2.2 Methods 
2.2.1 Physicochemical Characterization.  Commercial grade, nano-size TiO2 (Degussa 
Aeroxide P25) was a gift from Degussa Corp. (Parsippany, NJ) and used without further 
purification or treatment.  Although the physicochemical properties (e.g., particle size 
distribution, zeta potential, and dispersion stability) of P25 have been previously reported 
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(64, 91, 92), they were re-measured in the present study in the vehicles used to maintain and 
expose the cell cultures. These included Hank’s Basic Salt Solution (HBSS) and Dulbecco’s 
Modified Eagle’s Medium (DMEM).  Both HBSS and DMEM are high ionic strength 
solutions with high concentrations of divalent cations that cause P25 to aggregate. DMEM 
also contains low amounts of glucose and amino acids.  The physicochemical properties of 
P25 were measured in a slurry prepared from a 1 g/L suspension of P25 in HBSS or DMEM.  
Slurry concentrations (5-120 ppm) similar to those used to expose cells were used 
immediately after 1 min sonication. The particle size distribution was measured by dynamic 
light scattering (Malvern Zeta Sizer Nano ZS, Southborough, MA) over a 3 hr period to 
monitor the growth of the aggregates and to determine a stable aggregate size. For 
calculating particle size (volume average), the refractive index of the anatase form of TiO2 
(nD=2.49) (93) was assumed. The zeta potential was determined in both HBSS and DMEM 
from electrophoretic mobility (EM) measurements of a 30 ppm slurry (Malvern Zeta Sizer 
Nano ZS). The Helmholtz-Smoluchowski equation was used to correlate electrophoretic 
mobility to zeta potential.  The N2-BET specific surface area was measured using a Nova 
2200e BET surface area analyzer (Quantachrome, Boynton Beach, FL).  Samples were 
degassed in helium for 1 hr at 150°C prior to analysis (94). The dispersion stability, 
operationally defined as the resistance to sedimentation, was determined by measuring the 
sedimentation rate of P25 suspensions in HBSS or DMEM.  The optical density (λ=508 nm 
or 450 nm) of the suspension was monitored for 18 hr in a UV-visible spectrophotometer 
(Varian, Palo Alto, CA). There was a linear relationship between TiO2 concentration and UV 
response for all TiO2 concentrations evaluated. 
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2.2.2 Cell Culture Maintenance and Exposure.  BV2 microglia were grown in 225-cm2 cell 
culture flasks in DMEM supplemented with 10% Fetal Calf Serum (FCS) and 1% penicillin-
streptomycin (ATCC, Manassas, VA).  After reaching 85% confluency, cells were 
transferred to Corning 96-well plates.  To minimize light scatter during the 
spectrophotometric readings, cells were plated in clear bottom, black (fluorescence) or white 
(chemiluminescence) 96-well culture plates (Corning Inc., Corning, NY) and examined with 
a Molecular Devices (Sunnyvale, CA) Spectramax Gemini EM (fluorescence) or Lmax II 
384 plate reader (chemiluminescence).  Non-cytotoxic exposure concentrations were 
determined from measures of intracellular ATP taken after 1, 6, and 18 hr exposure to P25 
(2.5-120 ppm) using the CellTiter-Glo® assay.  For all ROS measurements, P25 was 
ultrasonicated (~1 min) in 10X stock concentrations in HBSS and exposed to the cells 
immediately before spectrophotometric readings were taken.   
 
2.2.3 Probes.  Fluorescent and chemiluminescent probes were chosen to measure the 
immediate generation of H2O2 resulting from the oxidative burst and that resulting from 
interference with mitochondrial ETC (95).  All probes were purchased from Molecular 
Probes (Eugene, OR) except for the chemiluminescent assay CellTiter-Glo® (Promega, 
Madison, WI).  The concentrations and incubation times for each assay were empirically 
derived and are described in the figure legends. For each fluorescent assay, cells, exposed to 
the fluorescent probe (i.e., “loaded”), were washed with HBSS to remove any extracellular 
probe from the cell’s external environment. In this way, only intracellular levels of ROS were 
measured.  Because it has been reported that P25 can be photo-activated by visible light (96), 
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all cell culture procedures (probe “loading”, washings, P25 exposures, etc.) were done under 
darkroom ”safe-lights”.  
The production of intracellular H2O2 generated from the oxidative burst was 
measured at 3, 5 min intervals with Image-iT™ and at 5-15 min intervals with OxyBURST® 
H2HFF Green BSA.  For Image-iT, cells were incubated (30 min, 37°C) with 25 µM probe in 
HBSS, washed and exposed to P25.  Fluorescence was recorded at 495/529 nm 
(excitation/emission).  For OxyBURST, cells were incubated with 10 µg/mL (30 min, 37°C) 
probe in reduced-serum media, washed and exposed to P25.  Fluorescence was recorded at 
508/528 nm.  The production of O2.- resulting from interference with the mitochondria’s ETC 
was measured using the mitochondrial specific fluorescent probe MitoSOX™ at 20 min 
intervals over a 0-120 min exposure.  Cells were incubated with 2 µM probe (10 min, 37°C), 
washed, and exposed to P25.  MitoSOX fluorescence was recorded at 510/580 nm.  Changes 
in the mitochondrial membrane potential, an indicator of the membrane’s net charge, were 
monitored with MitoTracker® Red over 20 min intervals.  Cells were incubated with 25 nM 
probe (10 min, 37°C), washed, and exposed to P25.  Fluorescence was recorded at 579/612 
nm.   Intracellular levels of ATP, an index of cell viability, were measured at 1, 6, and 18 hr 
post-exposure with a lucerifase-based chemiluminescence assay, CellTiter-Glo®.  
 
2.2.4 Statistics.  All data were collected using SoftMax Pro 4.8 software (Molecular Devices, 
Sunnvale, CA). Graphing and statistics were performed with either Excel 2003 (Microsoft, 
Redmond, WA) or GraphPad Prism 4.02 (GraphPad Software, San Diego, CA).   The mean 
value (n=6) at each concentration was graphed to show a time-course response.  At least five 
time points are depicted for each assay.  Data were analyzed using an unpaired two-tailed 
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Student’s T-test to determine the lowest statistically significant concentration relative to its 
unexposed baseline control.  The exposure concentration/time point at which a statistically 
significant difference was observed is indicated on the graphs (*, p < 0.05) and described in 
the figure legends.       
 
2.2.5 Transmission Electron Microscopy (TEM).  BV2 cells, grown to 85% confluency in 6-
well Costar plates (Corning), were exposed to P25 particles (2.5 ppm) in 1% reduced serum 
DMEM for 6 and 18 hr.  After exposure, cells were washed in warm HBSS to remove all 
non-internalized particles and fixed overnight in cold 4% cacodylate-buffered glutaraldehyde 
(Poly Scientific, Bayside NY).  Cells were centrifuged (1100 rpm, 5 min) and processed as a 
pellet for TEM using standard procedures (97).  Polymerized blocks were sectioned at 500-
700 nm thickness and examined with a Philips CM12 electron microscope. 
 
2.3 Results and Discussion   
2.3.1 Physicochemistry.  The toxicity of nanosize particles has been associated with several 
physicochemical characteristics, such as the N2-BET specific surface area, the zeta potential, 
and particle aggregate size.  These properties were measured in cell culture media (DMEM) 
and the physiological buffer (HBSS) used to expose the cells.  The N2-BET specific surface 
area of P25 was measured at 52.7 ± 3.6 m2/g and is consistent with the manufacturer’s data 
and with previous reports (91, 92, 94, 98).  The zeta potentials of P25, measured in DMEM 
(pH=7.5) and HBSS (pH=7.6) were -11.6 ± 1.2 mV and -9.25 ± 0.73 mV, respectively.  The 
negative surface charge at physiological pH (pH=7.5-7.6) was consistent with the commonly 
reported isoelectric point of pHIEP=6.4 for Degussa P25 (92, 94, 98).  Degussa P25 is a 
 15 
mixture of the rutile and anatase forms of TiO2 (70% anatase / 30% rutile) with a reported 
primary crystallite size of ~30 nm (91).  P25 rapidly aggregates in both HBSS and DMEM.  
Both HBSS and DMEM are high osmolarity fluids with approximate ionic strengths of 155 
mM and 166 mM, respectively, and both contain high concentrations of the monovalent 
cations  Na+ and K+ (160 mM) and the divalent cations Ca2+ and Mg2+ (2 mM).  Aggregation 
 
 
continued for 20-45 min after sonication (1 min), until a steady-state stable aggregate size 
formed (Figure 2.1).  The steady state aggregate size increased from 800 nm to 2400 nm as 
the concentration increased from 5 ppm to 120 ppm (Table 2.1). The size of P25 aggregates 
was the same in both HBSS and DMEM as these fluids had nearly identical ionic strength 
Figure 2.1.  Particle aggregation over time at various concentrations 
of Degussa P25 TiO2 in HBSS (open symbols) and in reduced 
serum DMEM (closed symbols).  The steady state aggregate sizes 
are reported in Table 2.1. 
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and composition. The amino acids and serum present in reduced-serum DMEM (but not in 
HBSS) did not significantly affect the rate of aggregation or the size of the aggregates.  
 
Table 2.1. Initial and steady state particle geometric mean hydrodynamic 
diameter for Degussa P25 TiO2 in HBSS or DMEM. 
 
Hydrodynamic Diameter (nm) TiO2 Dose 
Concentration Initial Steady-state 
5 ppm 500 ± 3a 826 ± 69b 
10 ppm 590 ± 3 1164 ± 85 
20 ppm 865 ± 32c 1284 ± 57c 
30 ppm 992 ± 19 1316 ± 68 
80 ppm 1570 ± 20 2090 ± 180 
120 ppm 1350 ± 30 2368 ± 163 
 
a
 Errors represent one standard deviation based on 3 replicate 
measurements. 
b
 Average particle size measured after reaching steady state (~30 min).  
Error bars represent 1 standard deviation of these values. 
c
 Measured in DMEM. 
 
During the 6, 18 hr exposure times described in the TEM studies, BV2 cells (which 
adhere to the bottom of the cell culture plate/well), were exposed by particle diffusion or 
sedimentation of aggregates. Such conditions are characteristic of cell culture studies and 
could produce higher particle exposures than that described by the concentration (99).  The 
sedimentation of P25 aggregates was measured in low serum media at 6, 18 hr exposure to 
estimate the fraction of particles that settled onto the cells during the TEM exposure (Figure 
2.2). By the end of the 18 hr exposure ~20% of the particles remained suspended in reduced 
serum DMEM.  The higher sedimentation rate seen at higher concentrations is consistent 
with larger sized aggregates formed at the higher test concentrations of P25 (see Table 2.1).  
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A correlation of P25 aggregate size (measured in HBSS) and the concentrations/times needed 
for significant ROS production is described in the Biological Effects section below. 
 
 
 
2.3.2 Biological Effects.  O2.-  is an unstable molecule which is quickly reduced to the more 
stable and measurable H2O2.   Kinetic analysis of H2O2 production measured both an 
immediate production of ROS as generated by the oxidative burst (Figure 2.3-A, 2.3-B) and 
by later release caused by disruption of mitochondrial ETC (Figure 2.4-A).  Microglia 
responded to P25 (≥ 10 ppm) with rapid (< 3-5 min) concentration-dependent formation of 
H2O2 as measured with Image-iT™ and OxyBURST® (Figure 2.3-A, 2.3-B).  In contrast to  
Figure 2.2. Degussa P25 sedimentation over 18 hours in HBSS or 
reduced serum DMEM at various concentrations.  Suspensions 
were sonicated for 1 minute prior to introduction into a cuvette.  
Absorbance was linear over the range of concentrations at the 
wavelengths used (λ=508 nm or 450 nm). 
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Figure 2.3. The extracellular release of H2O2 following P25 
exposure was measured using Image-iT™ (A) and OxyBURST® 
(B). An asterisk marks the lowest concentration/earliest timepoint 
with a significant (p < 0.05) increase in fluorescence relative to 
baseline, occurring at 3 min for Image-iT and 5 min for 
OxyBURST. 
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Figure 2.4. (A) Increases in O2.- were measured by the fluorescent 
probe MitoSOX™ Red.  (B) Mitochondrial membrane potential 
was monitored with MitoTracker® Red. An asterisk marks the 
lowest concentration/earliest timepoint with a significant (p < 0.05) 
increase in fluorescence relative to baseline, occurring at 60 min for 
MitoSOX™ and 20 min for MitoTracker® Red. 
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the rapid increases in H2O2 generated by the oxidative burst, significant release of ROS did 
not occur until 60 min post-exposure (≥ 20 ppm) as measured by MitoSOX™ (Figure 2.4-A).  
MitoTracker® Red is a potential-dependent dye.  Increases in MitoTracker® Red staining 
intensity indicate increases in the mitochondria’s membrane potential (i.e.,hyper-
polarization).  The fluorescent MitoTracker molecules, which are initially distributed 
throughout the cytoplasm, accumulate on negatively charged (anionic) membranes.  The 
increased fluorescence suggests a steady exposure concentration-dependent accumulation of 
net negatively charged O2.- within the mitochondrial membrane (Figure 2.4-B). This 
plausibly resulted from P25’s inhibition of one or more of the ETC enzymatic complexes 
(Complex I, III).  Depolarization of the mitochondrial membrane is normally associated with 
a reduction of membrane permeability, an opening of the mitochondrial transition pore, and 
the initiation of necrotic or apoptotic pathways (45, 85). MitoTracker® Red did not indicate 
membrane depolarization in response to P25.  This was supported by measures of 
intracellular ATP (Figure 2.5) which were maintained at all P25 concentrations throughout 
the 120 min exposure period, confirming that all cellular expressions of ROS release were 
measured in actively respiring and viable microglia.  
 A correlation between the size of P25 aggregates (Figure 2.2) and the “effective” 
exposures (i.e., earliest time point and lowest concentration resulting in significant ROS 
production) was examined. ROS generated from the oxidative burst (Image-iT™, 
OxyBURST®) indicated that significant increases occurred at 3-5 min in response to ≥10 
ppm P25. At this time and concentration, P25 aggregate size was ~750-800 nm. Significant 
increases in ROS generated from the mitochondrial ETC occurred >60 min exposure, in 
response to ≥20 ppm P25 as measured with MitoSOX™ probes.  At this time and  
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concentration, P25 aggregate size was ~1300 nm.  The relationship between “effective” 
exposures and aggregate size should be routinely measured in nanoparticle toxicity studies 
since aggregate size can have a profound impact on the cell’s uptake of particles and their 
response to that uptake. 
TEM indicated that after 6 hr exposure, P25 aggregates were phagocytized in small 
clusters and internalized within the microglia’s cytoplasm where they aggregated into 
electron-dense ~0.5-2 micron clumps (Figure 2.6 A, B).  The appearance of small (100-300 
nm) and large (800-2000 nm) particle aggregates was consistent with the recorded particle 
size distribution data (Figure 2.2).  Phagocytes (e.g., macrophages, microglia) preferentially 
engulf particles in the 1-3 µm range (100).  In contrast, nanosize particles (<100 nm) are not 
phagocytized in the strict sense, rather, they are engulfed through other, non-specified 
Figure 2.5. ATP levels in BV2 cells measured by CellTiter-Glo® 
chemiluminescence. ATP levels remained stable at all measured 
time points, indicating that all ROS and TEM measures were 
collected on viable microglia. 
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mechanisms which involve electrostatic, van der Waals and steric interactions (101).  
Ultrastructural evidence of swollen and disrupted mitochondria lying in close proximity to 
the aggregates of P25 was recorded after 18 hr exposure (Figure 2.6 C, D).  The appearance 
of swollen mitochondria suggests that the mitochondrial membrane permeability transition 
 
 
 
Figure 2.6. Electron micrographs of BV2 microglia exposed to P25. (A) 
Quiescent microglia are large, 8-10 micron phagocytic cells with many oval-
shaped mitochondria visible in their cytoplasm.  (B) An early (6 hr exposure) 
response of microglia to 2.5 ppm P25 was the elaboration of numerous 
pseudopodia which engulfed small groups of electron-dense particles (*).  (C) 
Within 18 hr post exposure, multiple vacuoles containing P25 aggregates were 
seen in proximity to pale-staining, swollen mitochondria.  (D) Higher 
magnification showed swelling and disruption of mitochondria lying in close 
proximity to the aggregates. 
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pore has begun to open and apoptotic or necrotic signals initiated (85, 86).  Still, the 
microglia remained viable in response to P25 exposure, since ATP intracellular levels 
showed no measurable reductions even after 18 hr exposures (Figure 2.5).   
In summary, these data demonstrate that nanosize P25 particles stimulate microglia to 
produce ROS through the oxidative burst and through interference with mitochondrial ETC.  
Nevertheless, the microglia remained viable at all concentrations of P25, in keeping with 
their known resistance to ROS damage (41, 102).  Whether the microglia’s release of ROS 
translates into neuronal damage in situ is not addressed in this study, but pilot data indicate 
that P25 stimulates apoptotic pathways in cultured neurons at concentrations >20 ppm  after 
24 hr exposure (103).  In contrast to earlier reports (104, 105), but in agreement with others 
(27), photo-activation of P25 does not appear necessary to stimulate ROS in microglia.   
Certain physical characteristics (e.g., surface charge, size, and surface area) of 
“incidental” nanosize particles such as airborne particulate matter (PM) are known to 
influence their toxicity.  It is plausible that similar physical properties of engineered 
nanoparticles could affect biological targets through OS or more novel toxicity pathways (17, 
106, 107).  Defining the causal mechanism(s) linking those physical properties with their 
biological effects should be a primary focus of nanotoxicity studies.  Studies on the 
inflammatory toxicity associated with nanosize particulate matter offer some insights into 
possible mechanisms.  Nanosize PM particles appear to mediate toxicity through OS 
pathways.  The pulmonary inflammation associated with their inhalation has been related to 
the large surface area of the ultrafine particles which exposes a high number of reactive 
groups on the particle’s surface (87, 108).  PM inflammation has also been correlated with 
the negative surface charge carried by the PM particle (109).  Polymodal, sensory receptors 
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embedded in the membrane of microglia and macrophages are possible target sites that could 
react to negatively charged nanoparticles.  For example, the activation of TRPV1 vanilloid 
sensory receptors by the negative surface charge carried on PM particles stimulates OS 
inflammatory pathways and the subsequent release of inflammatory cytokines from both 
respiratory epithelial cells (110) and BV2 microglia (111).  Scavenger receptors, found on 
microglia and macrophages (112), are also sensitive to repeating patterns of charge that may 
be found on ordered crystalline metal oxide nanoparticles. Such receptors have been 
implicated in mediating cytotoxicity in alveolar macrophages exposed to TiO2 (113).  In the 
present study, the negative zeta potential of P25 particles and the ordered arrangement of 
charged O- sites on their surface could be activating either type of receptor and subsequent 
OS pathways in the microglia. Future studies will examine the causal relationship between 
the surface charge of nanoparticles and OS mediated events in neurons and other cell types to 
better understand how the physical properties of particles interact and activate biological 
systems.  
 
  
 
 
 
3. NANOSIZE TITANIUM DIOXIDE STIMULATES REACTIVE OXYGEN 
SPECIES IN BRAIN MICROGLIA AND DAMAGES NEURONS, IN VITRO∗ 
 
3.1 Introduction 
The increased use of engineered nanoparticles in medical, agricultural, industrial, 
manufacturing, and military sectors raises legitimate concerns as to their adverse effects on 
environmental and biological targets. Nanosize titanium dioxide (TiO2) is used in a variety of 
consumer products (e.g. toothpastes, sunscreens, cosmetics, food products) (69), 
manufacturing, paints and surface coatings (64) and in the environmental decontamination of 
air, soil, and water (12). Such widespread use and its potential entry though dermal, 
ingestion, and inhalation routes suggest that nanosize TiO2 could pose an exposure risk to 
humans, livestock, and eco-relevant species. Although earlier studies have reported equivocal 
toxicity in experimental animals exposed to different particle sizes and formulations 
(nanosize, pigment grade, and surface coated) (72), more recent studies clearly indicate TiO2 
toxicity in eco-relevant species (i.e., E. coli, daphnia) (50) and mammals (30, 32). Numerous 
in vitro studies have reported OS-mediated toxicity in various cell types (27-29, 73, 78, 114). 
However, the response of nerve cells to nanosize TiO2 has not been investigated in vitro or in 
vivo, outside of a companion study (115).  
Because of their size and unusual properties, nanoparticles can enter the body and 
cross biological barriers relatively unimpeded. Several studies have reported that inhaled or 
injected particles enter systemic circulation (in low numbers) and migrate to various organs 
                                                 
∗
 Long, T.C.; Tajuba, J.; Sama, P.; Saleh, N.; Swartz, C.; Parker, J.; Lowry, G.V.; Veronesi, B.   Environ. 
Health Perspect. 2007, doi:10.1289/ehp.10216. 
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and tissues (35-37) where they could accumulate and damage organ systems that are 
especially sensitive to oxidative stress (OS). The brain is one such organ, being highly 
vulnerable to OS because of its high energy demands, low levels of endogenous scavengers 
(e.g., vitamin C, catalase, superoxide dismutase, etc.) and high cellular concentration of OS 
targets (i.e. lipids, nucleic acids, and proteins). Recent experimental studies indicate that 
nanoparticles can cross the blood-brain barrier (39) and enter (in low numbers) the central 
nervous system (CNS) of exposed animals (35, 38). 
In the brain, OS damage is mediated by the microglia, a macrophage-like, phagocytic 
cell that is normally inactive unless confronted by potentially damaging xenobiotics. Their 
immediate and characteristic response (i.e., “oxidative burst”) to foreign stimuli involves 
cytoplasmic engulfment (i.e., phagocytosis), an increase in metabolic activity, and a change 
in cell shape, size and proliferation (48). The NADPH-oxidase driven “oxidative burst” can 
be monitored by the immediate production and release of superoxide anions (O2.-) that 
convert to multiple ROS such as hydrogen peroxide (H2O2), hydroxyl radicals, and 
peroxynitrites. The excess O2.- arising from the oxidative burst can diffuse from the 
microglial plasma membrane and damage the proteins, lipids, and DNA of neighboring cells, 
especially neurons. Current thinking indicates that microglial-generated ROS underlies 
neurodegeneration (48). Although the oxidative burst is the major source of ROS in the 
activated microglia, O2.- is also generated as a by-product of normal mitochondrial energy 
production. This results from the inefficient transfer of electrons along the electron transport 
chain (ETC) (45). The levels of O2.- generated from the ETC are relatively low and 
efficiently neutralized by matrix-located antioxidant enzyme systems (i.e., endogenous 
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scavengers). However, the levels of ETC-generated O2.- can increase significantly if one or 
more of the enzymatic complexes in the ETC is inhibited.  
To examine the possible neurotoxicity of TiO2, nerve cells critical to the 
pathophysiology of neurodegeneration (i.e., microglia, neurons) were exposed to a 
commercially available nanomaterial, Degussa P25. The BV2 microglia is an immortalized 
mouse cell line that responds to pharmaceutical agents, particulates, and environmental 
chemicals with characteristic signs of OS (88, 89). Its biochemical, morphological and 
genomic response to P25 exposure was examined in the present study. Since certain neuronal 
populations (such as dopaminergic (DA) neurons found in the brain striatum) are especially 
vulnerable to OS (116), the neurotoxicity of P25 was studied in the N27, an immortalized rat 
DA neuronal cell line (117) and complex CNS cultures of embryonic rat striatum, which 
contains high numbers of DA neurons (118). Throughout the study, the physicochemical 
properties of P25 were described under exposure conditions that paralleled the biological 
response of these cells.  
 
3.2  Materials and Methods 
3.2.1 Physicochemical Characterization. Commercial grade, nanosize Degussa P25 is a 
mixture of the anatase and rutile forms of TiO2 (70% anatase/30% rutile). Anatase is the 
preferred form for use in catalysis due to its enhanced redox activity (119). Several 
physicochemical properties of nanosize particles such as zeta potential (i.e., surface charge) 
and particle aggregate size (120, 121) have been associated with toxicity. A companion study 
measured the effect of P25 concentration on aggregate size in physiological buffer and 
culture media (115). In the current study, the aggregate size and zeta potential of P25 at a 
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median concentration (20 ppm) was studied under conditions (vehicle, time point, 
temperature) that paralleled the biological response. Physicochemical properties of P25 (20 
ppm) were measured in Hank’s Basic Salt Solution (HBSS) at 25°C over a 120-min period to 
parallel the exposure parameters of ROS release in microglia. Measures were also taken in 
low serum (1%) culture media (RPMI 1640) at 37°C over 48 h to parallel the neurotoxic 
response of N27 neurons. A Zeta Sizer Nano ZS (Malvern, Inc., Southborough, MA) was 
used to measure the hydrodynamic diameter (size) of P25 using the intensity-averaged 
distribution and the electrophoretic mobility of P25 was used to calculate its zeta potential 
using the Helmholtz-Smoluchowski equation.  
 
3.2.2 Cell Culture. Immortalized mouse BV2 microglia and rat N27 mesencephalic neurons 
were grown, respectively, in Dulbecco’s Modified Eagle’s Medium (DMEM) or RPMI 1640 
medium that was supplemented with 10% Fetal Calf Serum (FCS) and 1% Penicillin 
Streptomycin (ATCC, Manassas, VA). Neurotoxicity studies, with exposure times ranging 
from 3-72 h, used low (1%) serum RPMI 1640 exposure media. Tissue plugs of embryonic 
rat (Sprague-Dawley) brain striatum were purchased (BrainBitsTM, Springfield, IL, 
http://www.brainbitsllc.com) and upon receipt were triturated and plated on poly-D-lysine-
coated 96-well plates (Nalge Nunc International, Rochester, NY) in Neurobasal/B27 media 
(InVitrogen, Carlsbad, CA).  
 
3.2.3 Assays. Fluorescent and chemiluminescent probes were chosen to measure the changes 
resulting from the oxidative burst and interference with mitochondrial ETC (Invitrogen Corp. 
2005). The immediate production of intracellular H2O2 generated from the oxidative burst 
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was measured in BV2 microglia with Image-iT™ LIVE Green, a dichlorodihydrofluorescein 
diacetate-based compound that reacts with intracellular esterases and fluoresces in the 
presence of ROS.  BV2 cells were incubated  (30 min, 37°C) in 25 µM Image-iT™ LIVE 
Green, washed, and exposed to P25. The production of O2.- resulting from interference with 
the mitochondria’s ETC was measured by incubating cells in 2 µM MitoSOX™ Red (10 
min, 37°C), washing, and exposing to P25. The viability and cytotoxicity of neuronal (N27) 
cultures were monitored using a lucerifase-based, chemiluminescence assay that measures 
intracellular levels of ATP (CellTiter-Glo®). Increases of caspase activity, an index of 
apoptotic entry, was measured in both BV2 microglia and N27 neurons with Caspase-Glo® 
3/7. Loss of nuclear material (i.e., cytotoxicity) was measured with Hoechst 33342 
(InVitrogen), a fluorescent probe that binds to adenine-thymine-rich regions of double-
stranded nuclear DNA and indicates apoptotic loss of nuclear material (Oancea et al. 2006). 
All fluorescent probes were purchased from Molecular Probes (Eugene, OR) except for the 
chemiluminescent assays, CellTiter-Glo® and Caspase-Glo® 3/7 (Promega, Inc., Madison, 
WI). 
For exposures, P25 (2.5-120 ppm) was ultrasonicated (~1 min) in 10X stock 
concentrations in either HBSS or low serum exposure media. For ROS measurements, cells 
were exposed to the fluorescent probe (i.e., “loaded”) and washed with HBSS to remove any 
extracellular probe from the cell’s external environment. 
 
3.2.4 Genomics and Bioinformatics. BV2 microglia were exposed (n = 3 wells/treatment) in 
6-well plates to P25 (20 ppm) for 3 h. Total RNA was extracted using TRIzol reagent 
(InVitrogen), purified, and its concentration determined using a NanoDrop ND-1000 
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Spectrophotometer (Wilmington, DE). Large-scale gene analysis was performed by 
Expression Analysis (Durham, NC) using the Affymetrix Mouse Genome 430 2.0 GeneChip 
oligonucleotide array (Affymetrix, Santa Clara, CA) which measures approximately 39,000 
transcripts. Target was prepared and hybridized according to the Affymetrix Technical 
Manual (www.expressionanalysis.com).  
Affymetrix CEL files were analyzed using GC-RMA (Wu et al. 2004) for array 
normalization and estimation of probe set intensities. Significance analysis of microarrays 
(SAM) (122) was used to identify genes differentially expressed between P25-treated 
samples and the media control. Significantly different up- and down-regulated genes were 
analyzed by Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, 
CA, http://ingenuity.com/index.html) to determine p-values associated with Core canonical 
(metabolic and signaling) pathways and Tox Solution, which identifies relevant toxicity 
phenotypes and clinical pathology endpoints. Probesets that related to OS genes were 
analyzed separately using an IPA master list. The ratio of list genes to pathway genes is 
presented along with the Fisher exact test p-value. Pathways above a p-value threshold of 0.1 
were discarded.  
 
3.2.5 Immunohistochemistry (IHC) and Morphometry. Cultures were fixed for 30 min in 
3.7% paraformaldehyde, blocked with a mixture of 1% BSA, 0.4% Triton X-100, and 4% 
normal horse serum (20 min, room temperature, RT), and incubated in a 1:200 dilution of 
monoclonal mouse anti-human, neuron-specific enolase (NSE) for 30 min at RT (Dako Inc., 
Ft. Collins, CO). Visualizaton with streptavidin followed protocol of the LSAB 2 System-HP 
kit from Dako. IHC stained striatal cultures were analyzed morphometrically for neuronal 
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loss. Six (10X) photographs of each well (n = 3/treatment) were taken using a Nikon TE300 
inverted microscope and a cooled-frame CCD camera (Orca I, Hamamatsu, Inc.). Each 
digitized image was analyzed using MetaMorph 7.0 software (Molecular Devices). 
Populations of control, NSE-stained neurons were “binned” according to size and shape 
parameters using the Integrated Morphometric Analysis mode. The total area of NSE-stained 
figures (cell bodies with attached axons) that fell within these parameters was calculated and 
compared to cultures treated with P25 (5 ppm; 6-48 h). Data were collected in Excel 2003 
(Microsoft, Redmond, WA) and transferred to GraphPad Prism 5 (Graphpad Software, Inc., 
www.graphpad.com, San Diego, CA) for graphing of the histogram. 
 
3.2.6 Light (LM) and Transmission Electron Microscopy (TEM). For TEM examination, cells 
were exposed in 6-well plates to P25 particles (20 ppm) for 3 h. After exposure, cells were 
washed in warm HBSS to remove all non-internalized particles and fixed overnight in cold 
2.5% cacodylate-buffered glutaraldehyde (Poly Scientific, Bayside NY). Cells were 
processed for TEM using standard procedures (97) and examined with a Zeiss LEO electron 
microscope. LM preparations were examined as toluidine blue stained 1-µm epoxy sections 
or in unstained glutaraldehyde-fixed samples. Both types of LM samples were photographed 
with a Nikon TE300 inverted microscope. 
 
3.2.7 Statistics. Spectrophotometric data were collected using SoftMax Pro 4.8 software 
(Molecular Devices). Graphing and statistics were done using Excel or GraphPad Prism 5. 
The mean response value (n = 6) of each concentration treatment was calculated. Data from 
several time intervals were normalized to show a time-course response. Data were analyzed 
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using a one-way ANOVA with Dunnett’s Test to determine significance (p < 0.05) relative to 
its unexposed control. Error bars representing the standard error of the mean are presented 
for data that are significantly different from the control.  The earliest time point and lowest 
concentration at which a significant difference was observed is indicated by an asterisk.  
 
3.3 Results 
3.3.1 Viability of BV2 Microglia. Measures of H2O2 released from both the oxidative burst 
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Figure 3.1. Response of BV2 cells to P25 exposure. (A) H2O2 released by the 
oxidative burst as measured by Image-iT™ LIVE Green. Standard error bars 
indicate significance, and the asterisk indicates the lowest concentration and 
earliest significant response. (B) Mitochondrial superoxide generation measured 
by MitoSOX™ Red. (C) Caspase 3/7 activity, an indicator of apoptosis. (D) 
Apoptotic loss of nuclear material measured with Hoechst stain. 
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and inhibition of the ETC were collected.  BV2 microglia responded to P25 at ≥ 60 ppm with 
a rapid (1-5 min) release of H2O2 as measured with Image-iT™ LIVE Green (Figure 3.1-A).  
Significant release of O2.- as measured by MitoSOX™ Red first occurred at 30 min in 
response to ≥ 100 ppm P25 and only responded to concentrations ≥ 60 ppm after 70 min 
exposure (Figure 3.1-B).  Significant increases in Caspase 3/7 activity, which signal the cell’s 
entry into apoptosis (45), were first measured at 6 hr in response to ≥ 40 ppm P25 and 
remained at this level by 24 hr (Figure 3.1-C).  BV2 cells showed reduced nuclear staining in 
response to ≥ 100 ppm P25 after 24 h and ≥ 2.5 ppm P25 after 48 h exposure as measured by 
 
 
Figure 3.2. Light (A, B) and transmission electron (C, D) micrographs of BV2 microglia 
exposed to 20 ppm P25. (A) Toluidine blue stained BV2 microglia, 3 h exposure. (B) 
Unstained, fixed cells exposed to P25 for 48 h. (C, D) BV2 exposed to P25 for 3 h. 
 34 
Hoechst dye (Figure 3.1-D). LM examination of BV2 microglia exposed to P25 (20 ppm) 
indicated that they internalized aggregates of P25 in small clusters by 3 h exposure (Figure 
3.2-A) and by 48 h responded with fragmented cellular membranes and numerous condensed 
nuclear figures, suggestive of apoptosis (Figure 3.2-B). Ultrastructural examination of the 
BV2 microglia indicated phagocytic internalization of the P25 (20 ppm, 3 h) (Figure 3.2-C) 
and swollen, disrupted microglia in the vicinity of these aggregates (Figure 3.2-D). 
 
3.3.2 BV2 Genomics and Bioinformatics. SAM identified 1755 probesets that were 
differentially expressed (1195 up-regulated, 560 down-regulated) in P25-treated cultures 
relative to medium controls. Core analysis with IPA indicated that the up-regulated genes 
were clustered around signaling pathways involved with B-cell receptor (gene transcription 
in the immune response), the death receptor (TNF receptor family; apoptotic initiating 
pathways; caspase activation), apoptosis, calcium and inflammation (NF-κB). Up-regulated 
cell cycling and maintenance pathways included ERK/MAPK signaling (growth factors for 
cell proliferation, differentiation, migration, survival, and fate) (Figure 3.3-A). Analysis of 
the up-regulated genes using the toxicity pathway feature of IPA indicated major pathways 
associated with inflammation (NF-κB), cell cycling, oxidative stress (peroxisomes) and pro-
apoptotic activities (Figure 3.3-B). The down-regulated pathways associated with P25 
exposure included several that were associated with adaptive change (e.g., B Cell receptor, 
ERK/MAPK) and energy production (glycolysis, gluconeogenesis, oxidative 
phosphorylation) (Figure 3.4-A). Toxicity analysis indicated that pathways triggered by 
response to low oxygen availability (i.e., hypoxia-inducible factor), peroxisomes, and NRF-2 
 35 
mediated oxidative stress were also downregulated (Figure 3.4-B).  IPA core analysis of OS 
genes affected by P25 indicated that key energy pathways involving oxidative  
 
 
 
phosphorylation, biosynthesis of ubiquinone (involved in shuttling electrons in the ETC) and 
the citric acid cycle were primarily down-regulated (Figure 3.5-A). Toxicity pathway 
A 
B 
Figure 3.3. Pathways significantly associated with up-regulated genes following 
exposure of microglia to P25 (20 ppm, 3 h). Ratio represents the fraction of total 
pathway genes that were identified as up-regulated. (A) IPA core metabolic and 
signaling pathways. (B) IPA toxicity pathways. 
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analysis indicated that P25 OS related genes were exclusively clustered around pathways 
associated with mitochondrial dysfunction (Figure 3.5-B). 
 
 
 
 
 
 
A 
B 
Figure 3.4. Pathways significantly associated with down-regulated genes following 
exposure of microglia to P25 (20 ppm, 3 h). Ratio represents the fraction of total 
pathway genes that were identified as down-regulated. (A) IPA core metabolic and 
signaling pathways. (B) IPA toxicity pathways. 
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3.3.3 Neurotoxicity. The direct (in the absence of microglia) neurotoxicity of P25 and that 
mediated by microglia-generated ROS was addressed, respectively, in isolated rat DA 
neurons (N27) and in primary cultures of rat striatum. P25 increased intracellular levels of 
ATP in N27 beginning at 1 h (≥ 80 ppm) and continued over 48 h (≥ 40 ppm) (Figure 3.6-A). 
Caspase 3/7 activity, an indicator of apoptosis, significantly increased at both 24 h and 48 h 
exposure (≥ 40 ppm) (Figure 3.6-B). Apoptotic damage to isolated N27 neurons, using  
A 
B 
Figure 3.5. Pathways significantly associated with oxidative stress genes following 
exposure of microglia to P25 (20 ppm, 3 h). Ratio represents the fraction of total 
pathway genes that were differentially expressed in microglia. (A) IPA core 
metabolic and signaling pathways. (B) IPA toxicity pathways. 
 38 
 
 
 
Hoechst 33342 nuclear stain, was not seen even after a 72 h exposure to P25 (2.5-120 ppm) 
(Figure 3.6-C). 
Ultrastructurally, both nanosized and large aggregates of P25 were seen in the N27 
cytoplasm after 3 h exposure to P25 (20 ppm). P25 aggregates were randomly located 
thoughout the neuronal cytoplasm (Figure 3.6-D) and appeared to be encased in membrane-
bound vacuoles (Figure 3.6-D, inset). No evidence of phagocytosis or pinocytosis (i.e., 
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Figure 3.6. Response of N27 neurons to P25 exposure.  (A) ATP levels in N27 
neurons following exposure to P25. (B) Caspase activity in N27 neurons in response 
to P25 exposure. (C) Hoechst nuclear staining of N27 neurons after P25 exposure. 
(D) Transmission electron micrographs of N27 neurons exposed to P25 (20 ppm, 3 
h). An amorphous substance was seen within the vacuoles (inset).  
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elaboration of pseudopodia) was observed, suggesting that the particles impacted the cell 
body by sedimentation. In contrast to the disrupted organelles noted above in BV2 microglia, 
mitochondria appeared ultrastructurally normal in the N27 neurons, in spite of their close 
proximity to P25 aggregates. 
IHC stained cultures of rat brain striatum, exposed to P25 (5 ppm) were photographed 
(Figure 3.7-A-D) and analyzed morphometrically. Results indicated that the total area of  
 
 
Figure 3.7. Light micrographs of immunohistochemically stained primary cultures of 
embryonic rat striatum. (A) Untreated confluent cultures containing neurons and glia. (B) 
Axonal beading and cellular granularity were seen as early as 6 h post-exposure. (C) Evidence 
of apoptosis (circles) was documented by 24 h. (D) Complete disruption and loss of cellular 
integrity was noted by 48 h post-exposure to 5 ppm P25. 
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NSE stained neurons was reduced by 14% after by 6 h exposure and by 19% after 24 h 
exposure (data not shown). 
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Figure 3.8. Size and zeta potential measurements of 20 ppm P25 
in HBSS (A) and RPMI media (B) at times that paralleled the 
exposure times for the biological responses. Open squares, 
aggregate size; open triangles, zeta potential.  
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3.3.4 Physicochemistry. The aggregate size and zeta potential of P25 (20 ppm) were 
measured in relevant exposure vehicles (HBSS, RPMI) at time points that paralleled the 
biological response (Figures 3.8-A, 3.8-B). In HBSS, the hydrodynamic diameter of P25 
aggregates ranged from 800 to 1900 nm (30 min) and decreased to 770 nm (2 h) as the larger 
aggregates settled from solution. The zeta potential of P25 (20 ppm) in HBSS (pH = 7.6) 
ranged from -9.78 to -13.8 mV after 2 h (25°C) (Figure 3.8-A). In low-serum RPMI exposure 
medium, P25 quickly aggregated but remained relatively stable in suspension (300-350 nm) 
over the 48 h exposure period. The zeta potential ranged from -8.54 to -10.1 mV over 0-48 h 
(37°C) in low-serum RPMI media (Figure 3.8-B). 
 
3.4 Discussion 
The present data indicate that Degussa P25 stimulates BV2 microglia to release ROS 
and affects genomic pathways associated with cell cycling, inflammation, apoptosis and 
mitochondrial bioenergetics. Adaptive pathways such as ERK/MAP kinase signaling (123) 
were differentially affected, indicative of attempts to adjust to the exposure conditions.  The 
significant association of differentially expressed genes with the biosynthetic pathway for 
ubiquinone, which functions as an electron carrier in the mitochondrial ETC and also acts as 
an antioxidant (124), and with mitochondrial bioenergetic pathways involving oxidative 
phosphorylation and glycolysis may reflect high levels of ROS and ultimately OS in the cell 
(45). P25 appeared to be non-toxic to isolated DA neurons (N27) even after 72 h. However, 
when examined in primary cultures of brain striatum which contain microglia, neuronal loss 
occurred by 6 h in response to only 5 ppm. This shift in dose-response, coupled with cellular 
and genomic evidence of P25’s effect on inflammatory and apoptotic pathways and 
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disruption of energy pathways in BV2 microglia, suggest that the potent neurotoxicity of P25 
seen in complex cultures was mediated though microglia-generated ROS. Apoptosis is a type 
of OS-mediated cell death (125). The microglia’s release of H2O2 from the oxidative burst 
and ETC, if excessive, can activate caspase 8 and its downstream effectors caspase 3/7, 
inducing apoptosis though ‘‘extrinsic’’ cell death pathways (85). Stimulation of 
mitochondrial apoptotic pathways (e.g. caspase 3/7) was noted biochemically and by gene-
expression analysis in BV2 microglia, and apoptotic morphology was shown in both isolated 
BV2 microglia and in cultures of striatum. These data indicate that OS-mediated apoptosis 
played a signature role in P25 neurotoxicity.  
Ultrastructurally, the phagocytosis of P25 aggregates by BV2 microglia and the 
strong association of mitochondrial disruption with these aggregates have been previously 
reported (115). Fractal aggregates can maintain their large surface area, sharp crystallite 
edges, and other characteristics of individual nanoparticles (7). Membrane-bound P25 
aggregates were also seen within the N27 cytoplasm. However, no morphological evidence 
of phagocytosis, pinocytotosis or endocytosis was noted. Because of this, the possibility that 
P25 aggregates sedimented from the exposure medium onto the cells and became 
incorporated into cytoplasmic lysosomes cannot be excluded. Nanosize particles were also 
documented lying free in the neuronal cytoplasm. The manner by which such nanoparticles 
enter the cell cytoplasm is still a matter of discussion and is thought to involve mechanisms 
distinct from phagocytosis and endocytosis (34); also, no effect of surface charge or particle 
composition was seen in entry of  nanoparticles into red blood cells (126). However, particle 
agglomeration may reduce translocation (127). 
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The biological interactions of nanoparticles are associated with physical properties 
such as surface area, particle shape, zeta potential, and aggregate size (120). For valid 
interpretation of nanoparticle toxicity data, these properties must be determined under 
conditions that parallel the biological exposures. These data indicated that the exposure 
conditions (i.e., vehicle, temperature) significantly modified P25’s particle size and zeta 
potential which could affect its interaction with biological systems and its ultimate toxicity. 
Particle (or aggregate) size determines if a particle enters the cellular environment though 
ROS-producing phagocytosis, through endocytosis, or some undefined mechanisms (128, 
129). The surface charge or zeta potential of a particle affects its aggregation in solution and 
its behavior in an electric or ionic field. The surface charge of a particle also determines its 
interactions with specific biological receptors. Polymodal receptors located in the cellular 
membrane of microglia and macrophages (e.g., TRPV1, Mac-1 etc.) are sensitive to protons 
(i.e., charge) or repeating patterns of charge (48, 112, 130) like those found on crystalline 
metal oxide nanoparticles.  The activation of these receptors triggers various signal 
transduction pathways that determine the cell’s ultimate fate. Scavenger receptors have been 
implicated in mediating the cytotoxicity of alveolar macrophages exposed to TiO2 (113). 
Studies have also shown that TRPV1 receptors located on rat primary microglia stimulate 
OS-mediated apoptotic cell death (131). The role of these receptors in mediating P25 
apoptosis in BV2 microglia is currently being examined using pharmacological and 
electrophysiological endpoints.  
In summary, this study describes the in vitro neurotoxicity of a widely used nanomaterial, 
P25. This material appears to be non-toxic to isolated N27 neurons but stimulates BV2 
microglia to produce ROS and damages OS-sensitive neurons in cultures of brain striatum.
  
 
 
4. TOXICITY TO ESCHERICHIA COLI AND CORRESPONDING GENE 
EXPRESSION PROFILES FOLLOWING EXPOSURE TO ZERO-VALENT IRON 
AND TIO2 NANOPARTICLES∗ 
 
4.1 Introduction 
The enhanced properties of manufactured nanomaterials relative to those of their bulk 
counterparts has driven much research into the use of nanotechnology in pharmaceuticals, 
materials science, consumer products, and environmental applications. As of July 2007, more 
than 500 consumer products claiming to incorporate nanotechnology were on the market 
(132). Environmental uses are another growth area for nanotechnology, with development of 
applications in sensing, drinking water treatment, air decontamination, and remediation of 
contaminated soil and groundwater (4, 133-137). As research and development on 
nanotechnology continues, accompanying risk research will be critical for environmental 
protection and for public acceptance of these technologies (120, 138). 
Two of the most widely used nanomaterials at present for treatment and remediation 
are zero-valent iron (ZVI) and TiO2. Micron-sized particles of both of these materials have 
been widely used, and nanosize versions are being investigated as improvements due to 
increased surface area and catalytic ability (139). Nanoscale ZVI has been applied at more 
than 20 pilot- and field-scale sites since 2001 for treatment of chlorinated solvents (1), and is 
being evaluated for treatment of arsenic and other metals (2, 3), polychlorinated biphenyls (4, 
134), and nitrate-containing compounds such as munitions (5). ZVI acts as a reductant in the 
environment, and correspondingly oxidizes to form magnetite (Fe3O4) and other iron oxides. 
                                                 
∗
 coauthored with Ambrose, W.; Swartz, C.; and Aitken, M.D. 
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These oxides have less reducing power, although catalytic activity can occur on their surfaces 
(140). ZVI is typically injected into the subsurface as a slurry and has limited mobility, 
adsorbing to mineral surfaces close to the injection site at length scales of centimeters to 
meters (6). Rapid agglomeration is observed for ZVI, as with other nanoparticles, but the rate 
is enhanced due to magnetic effects (7). Efforts are underway to increase mobility and 
targeting of non-aqueous-phase contaminants by surface modification of ZVI (8, 9). Despite 
agglomeration of unmodified ZVI, nano-scale features of the aggregates are still observable 
(7). 
TiO2 has been used for photocatalytic applications in combination with UV light to 
oxidize contaminants in air, drinking water, and soil (10-13). TiO2 acts as a semiconductor 
when irradiated with UV light of sufficient energy (wavelength >380 nm) to dislodge 
electrons from the crystal structure. These electrons may recombine or form reactive oxygen 
species (ROS), which are available for redox reactions with inorganic and organic pollutants 
(14, 15). Of the two primary crystalline forms of TiO2 in commercial use (anatase and rutile), 
anatase is the more photoactive. Doping of TiO2 with other elements such as nitrogen is 
being pursued to expand the photocatalytic activity into the visible range (16). Catalysis in 
the absence of light activation is greatly reduced or negligible. 
Several investigators have begun to explore the toxicity of nanoparticles, including 
ZVI and TiO2. The toxicity of ZVI or its oxidation product magnetite has been examined in 
mammalian cells (19, 20, 141), but no published reports are available on nanoscale ZVI 
toxicity to bacteria or other organisms in the environment. TiO2, one of the most studied 
nanoparticles, has been found to exhibit mammalian toxicity in vitro (27, 29, 115) and in 
vivo (30, 32), possibly through inflammatory responses and stimulation of macrophages to 
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produce ROS. In species that do not possess these response mechanisms, TiO2 is less toxic in 
the absence of light than other oxide nanoparticles such as MgO and ZnO, which can disrupt 
microbial membranes (33, 50, 58). Toxic effects on bacteria have also been observed for 
other types of nanoparticles, such as fullerenes (55, 56), which can be mitigated by surface 
derivatization (59). Of the limited evidence available, it appears that particle composition, as 
well as charge and other surface properties, affect the biological response to nanoparticles.  
The present study was designed to extend the research on potential effects of 
commercially available ZVI and TiO2 nanoparticles to microorganisms. E. coli was chosen as 
the target species because its physiology is well understood and because whole-genome 
microarrays are commercially available for E. coli. The toxicity to E. coli was evaluated for 
up to 500 parts per million (ppm) ZVI and up to 2000 ppm TiO2. Gene expression profiles of 
E. coli were then obtained with whole-genome microarrays after exposure to sublethal doses 
of each type of nanoparticle, and the results were corroborated with other biological 
endpoints (mutagenicity and respirometry). Electron microscopy was used to examine the 
localization of nanoparticles in exposed cells, and physicochemical properties of the 
nanoparticles were measured in the presence and absence of cells to characterize their 
agglomeration state and charge in biological media. To my knowledge, this is the most 
comprehensive investigation of effects of environmentally relevant nanoparticles on bacteria 
conducted to date. 
 
4.2 Materials and Methods 
4.2.1 Physicochemical Characterization of Nanoparticles. Nanoscale ZVI was obtained from 
Toda Kogyo (Hiroshima, Japan) in Februrary 2007 (Lot No. 061203) and stored in an 
 47 
anaerobic chamber (1% H2, balance N2). Single-use aliquots were prepared in the chamber in 
1.8-mL crimp-cap vials to limit ZVI oxidation. These particles have a core-shell structure, 
with a core of Fe0 and a magnetite shell (Fe3O4). The physical and chemical properties of 
nano-ZVI have been published (7, 134, 142). The manufacturer reported a primary particle 
size of 28 nm and a BET specific surface area of 20 m2/g. The iron content was measured to 
be 38%. Just prior to use, the slurry was sonicated and diluted 100-fold in phosphate-buffered 
saline (PBS, Gibco) to yield a 3.3 g/L stock suspension. This stock was further diluted to 
make 2X working suspensions, which were sonicated (~1 min) prior to bacterial exposure. 
 Nanoscale TiO2 (Degussa P25) was obtained as a powder from Degussa Corp. 
(Frankfurt/Main, Germany). The manufacturer reports the crystal composition of P25 to be 
approximately 70% anatase and 30% rutile, with a primary crystallite size of 20-30 nm. The 
BET specific surface area of P25 was previously measured to be 53 m2/g (115). Working 
suspensions (2X) were prepared in PBS and sonicated (~1 min) prior to bacterial exposure. 
 Particle size was measured by dynamic light scattering using a Zetasizer Nano ZS 
(Malvern, Southborough, MA). Both ZVI and TiO2 formed aggregates that settled to the 
bottom of the culture tube during incubation/shaking. Samples of the suspension, which 
included visible bacterial turbidity as well as color indicating the presence of ZVI or TiO2, 
were removed after 1 h exposure and analyzed for particle size. Size values are reported as 
the intensity distribution. Particle size was also measured in the absence of bacteria at t=0 
and after 1 h shaking to mimic exposure conditions. Electrophoretic mobility measurements 
by the ZetaSizer were used to calculate the zeta potential of these suspensions with the 
Helmholtz-Smoluchowski equation. 
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4.2.2 Bacterial Cultures. Escherichia coli strain MG1655 (also referred to as E. coli K-12) 
was obtained from the American Type Culture Collection (Manassas, VA). Strain K-12 is a 
laboratory strain that has been used as the reference for E. coli genome sequencing (143). E. 
coli strains WP2 uvrA / pKM101 (designated strain IC188) and its derivative deficient in the 
OxyR protein, WP2 uvrA oxyR / pKM101 (designated strain IC203) were kindly provided by 
Dr. Manuel Blanco of the Prince Phillipe Research Institute (Valencia, Spain). These 
tryptophan auxotrophs are the basis of a reverse mutation assay similar to the Ames 
Salmonella assay for detecting the effect of ROS on promotion of mutagenesis. OxyR is a 
transcription factor that enhances the expression of antioxidant enzymes such as catalase, 
alkyl hydroperoxidase, and glutathione reductase (144), and its deficiency in strain IC203 is 
responsible for increased reversion rates relative to strain IC188 under conditions that lead to 
oxidative stress. Strains were re-isolated prior to reversion experiments according to standard 
protocols (145) on Luria-Bertani (LB) agar plates containing ampicillin; for strain IC203, 
plates were supplemented with 200 units of catalase to enhance growth. 
 
4.2.3 Viability Assays. E. coli K-12 was grown overnight (~16 h, 37 °C, 250 rpm) in M9 
minimal salts supplemented with 2 g/L glucose to reach an OD600 of approximately 1 
absorbance unit. Cultures were exposed to nanoparticles by mixing with an equal volume of 
2X suspension (treated) or PBS (controls). Exposed cultures were shaken and incubated in 
the dark for 1 h (37 °C, 250 rpm). After exposure, 106 dilutions of the cell suspensions were 
plated on M9-glucose plates (15% agar), incubated for 48 h at 37 °C, and counted for 
surviving colonies. Cultures were plated in duplicate, and each experiment was repeated at 
least three times.  Statistical significance of pooled values from all experiments was 
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determined by one-way ANOVA with Dunnett’s multiple comparison test. 
 
4.2.4 Reversion Assays. Overnight cultures (14-16 h) of strains IC203 and IC188 were 
inoculated from frozen stocks and grown at 37 °C (no shaking) in Nutrient Broth No. 2 
(Oxoid Ltd, Hampshire, UK) containing 25 µg/mL ampicillin. Pre-existing mutants were 
counted by plating 0.1 mL of overnight culture on minimal E4 plates (no tryptophan) 
containing 15 g Bacto-agar and 4 g glucose per liter of Vogel-Bonner E medium (145). 
Cultures were exposed to nanoparticles by mixing with an equal volume of 2X suspension 
(treated) or PBS (controls). Exposed cultures were incubated in the dark without shaking for 
1 h at 37 °C.  After exposure, 0.1 mL of culture was mixed with 2.5 mL of warm top agar (6 
g/L agar, 5 g/L NaCl) and plated on ET4 plates (E4 supplemented with 0.5 mg/L tryptophan) 
to count Trp+ revertants arising spontaneously (control) and following exposure (treated). 
Menadione (2-methyl-1,4-naphthoquinone) and 4-nitroquinoline-1-oxide (4-NQO) were used 
as positive controls to induce reversion in strain IC203 and strain IC188, respectively. 
 
4.2.5 Respirometry. Oxygen uptake rate (OUR) measurements were made with a water-
jacketed reaction vessel (Gilson Medical Electronics, Middleton, WI) fitted with a Clark-type 
oxygen electrode that was connected to a YSI, Inc. (Yellow Springs, OH) Model 5300 
biological oxygen monitor. Data were collected with a WinDAQ (DATAQ Instruments, Inc., 
Akron, OH) data acquisition system and downloaded to an Excel (Microsoft Corp., 
Redmond, WA) spreadsheet for processing. A single overnight culture was used for all 
exposures in each respirometry experiment. Cultures exposed in the same manner as for the 
viability assays (1 h) were added to the reaction vessel and the OUR measured. To test the 
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effect of additional substrate, a small volume of concentrated glucose solution was injected to 
produce a concentration increase of 2 g/L, and the initial rate of oxygen uptake was 
measured. Net OUR was calculated by subtracting the rate prior to glucose injection from the 
rate in the presence of glucose. The background OUR of ZVI and TiO2 in cell-free 
suspensions was also measured. 
 
4.2.6 RNA Extraction and Microarray Preparation. Overnight cultures of E. coli K-12 grown 
in M9/glucose media (~16 h, 37°C) were exposed to nanoparticle suspensions (1 h) as for the 
viability assays.  Sub-lethal exposure concentrations for ZVI (50 ppm) and TiO2 (200 ppm) 
were selected based on viability results.  RNA was extracted with the Qiagen RNeasy Protect 
Bacteria Mini kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer’s 
protocols. Briefly, stabilization reagent was added to preserve the RNA expression profile, 
cells were enzymatically lysed with lysozyme, and the lysate was passed through a silica 
membrane to bind nucleic acids. DNase I was added to the membrane to digest DNA. After 
an ethanol-water rinse, RNA was eluted with RNase-free water. RNA quality (A260/A280 
ratio) and quantity (A260 absorbance) were measured with a NanoDrop (Wilmington, DE) 
ND-1000 spectrophotometer. RNA samples were also checked for degradation with an 
Agilent (Santa Clara, CA) 2100 Bioanalyzer. To obtain sufficient RNA quantity and 
concentration for microarray hybridization, RNA was extracted from duplicate samples and 
pooled in a 1:1 ratio, then concentrated using a vacuum evaporator. One such pooled and 
concentrated sample was used for each microarray. 
 Gene expression was measured using Affymetrix (Santa Clara, CA) E. coli 2.0 
GeneChip microarrays. These arrays include approximately 5000 probesets from the 
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MG1655 (K-12) strain. Four arrays were used for PBS-exposed control cultures, and three 
arrays each were used for ZVI- and TiO2-exposed cultures. Array hybridization, washing, 
and scanning procedures followed the Affymetrix GeneChip Expression Analysis Technical 
Manual. Briefly, cDNA was synthesized from the RNA using random primers, then cleaned 
up by column purification following NaOH degradation of RNA. The cDNA was fragmented 
and end-labeled with a biotinylated reagent, then loaded onto the microarray. Arrays were 
incubated overnight at 45 °C to hybridize fragmented and labeled cDNA to the 
oligonucleotides on the array. The arrays were then washed, stained with streptavidin, and 
scanned to measure hybridization intensity. 
Pixel intensity values from the scanned images (DAT files) were converted to raw 
probe intensity values (CEL files) by Affymetrix GCOS software. The CEL files were 
imported into GeneSpring GX and GC-RMA (Robust Multi-array Average modified to 
consider probe GC content) was used for background correction and quantile normalization 
(146). The GC-RMA technique enables comparison of expression values across all arrays in 
the experiment by correcting for intensity differences arising during hybridization and 
scanning.  Based on this analysis and review of the heat maps, one array (for TiO2) was 
excluded from further analysis because of much lower overall intensity than the other nine 
arrays. SAM (Statistical Analysis of Microarrays) (122) was used to identify genes that were 
differentially expressed between treatments and controls. Results were restricted to genes 
whose expression differed by a factor > 2.0 with a false discovery rate (FDR) (147) less than 
3%. Lists of up- and down-regulated genes were annotated for pathway and keyword 
associations using the Database for Annotation, Visualization, and Integrated Discovery 
(DAVID; National Institute of Allergy and Infectious Diseases; 
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http://david.abcc.ncifcrf.gov/home.jsp). Additional information was obtained from the 
primary databases compiled in DAVID, such as UniProt 
(http://www.pir.uniprot.org/index.shtml). Functional cluster analysis was performed using 
DAVID to identify common pathways and keywords associated with the entire lists of up- 
and down-regulated genes for ZVI and TiO2. This technique uses a statistical approach 
(Fisher exact test) to determine whether more genes from the list are represented in a certain 
pathway than would be expected by random selection of genes from the entire genome. In 
this way, information from the entire list of genes can be used to identify biological themes 
rather than focusing on a few prominent genes. 
 
4.2.7 Electron Microscopy. Overnight cultures of E. coli K-12 grown in M9/glucose media 
(~16 h, 37°C) were exposed to nanoparticle suspensions (1 h, shaking at 250 rpm) as for the 
viability assays at the same sub-lethal concentrations used in gene expression analysis.  
Suspended cells and particles were removed from the culture tubes and gently centrifuged to 
form a pellet.  The pellet was resuspended in fixative (2.5% glutaraldehyde, 2% 
formaldehyde, 0.1 M cacodylate buffer) and fixed at 4°C for 1 h.  For scanning electron 
microscopy (SEM), a drop of the suspension was placed on a poly-L-lysine-coated glass 
coverslip and allowed to attach for 30 min.  The coverslip with attached cells was briefly 
washed, taken through a dehydration series (50%, 70%, 95% ethanol for 5 minutes each, then 
through two rinses of absolute ethanol for 10 minutes each) before critical-point drying  
(Polaron 3100, Quorum Technologies, Newhaven, UK) using liquid CO2 as transition fluid. 
Coverslips were then mounted onto aluminum planchets with carbonized, double sided 
adhesive tabs and sputter coated (Polaron E5100) with a gold/palladium alloy.  Samples were 
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imaged with a JEOL 6300 scanning electron microscope (JEOL America, Peabody, MA) 
operating at 15 kV accelerating voltage.  The microscope was equipped with an X-ray 
microanalyzer (Kevex Sigma 3, Thermo Scientific, Waltham, MA) for spectroscopic 
elemental analysis.   
For transmission electron microscopy (TEM), the fixed suspension was pelleted. The 
pellet was rinsed with 0.1 M cacodylate buffer and post-stained with 2% osmium tetroxide in 
the same buffer for 1 hour. After thorough rinsing with deionized water, the pellet was 
dehydrated with a series of ethanol solutions (50%, 70%, 95% five minutes each and then 
two changes of absolute ethanol for 10 minutes each) and finally transferred to two changes 
of propylene oxide for ten minutes each. Infiltration with epoxy resin (Eponate 12, Ted Pella, 
Inc., Redding, CA) was carried with a 50:50 dilution with propylene oxide for four hours 
with rotation, and then embedding was carried out with resin alone in vacuum overnight at 
room temperature.  The samples were then placed into an oven to cure for two days. 
Specimen blocks were sectioned at 90 nm and mounted onto uncoated 200 mesh copper 
grids. Grids were stained with uranyl acetate and lead citrate and imaged with a Philips 
CM12 TEM  (FEI Inc, Hillsboro, OR) at 100 kV accelerating voltage . All images were 
collected digitally in .TIF format. 
 
4.3 Results 
4.3.1 Toxicity to E. coli K-12. ZVI significantly reduced viable plate counts relative to 
unexposed cells after 1 h incubation at concentrations of 100-500 ppm (Figure 4.1-A). A 
slight, though not statistically significant, loss of viability was observed at 20-50 ppm (Figure 
4.1-A). TiO2 did not reduce plate counts after 1 hr at any concentration tested (50-2000 ppm) 
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Figure 4.1. Effects on viability of E. coli K-12 cultures after 
exposure to ZVI (A) or TiO2 (B) for 1 h at 37°C. Values and error 
bars represent the mean and standard deviation of at least three 
replicate experiments, each consisting of duplicate plates. 
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(Figure 4.1-B). Longer incubations (up to 24 hr) did not produce statistically significant 
reductions relative to 1 h incubations (data not shown).  Cultures used for gene expression 
analysis did not show statistically significant loss of viability relative to controls at a ZVI 
concentration of 50 ppm or a TiO2 concentration of 200 ppm. 
 
4.3.2 Mutagenicity Assays. The change in reversion rate for treated cultures relative to 
control (unexposed) cultures is presented in Figure 4.2. A two-fold increase or greater is 
considered evidence of mutagenicity (148). ZVI exposure (Figure 4.2-A) did not 
significantly increase the reversion rate for either strain IC203 or strain IC188 at any 
concentration tested (20-500 ppm). An apparent decrease in reversion rate at high ZVI 
concentrations, which was not statistically significant, may have been due to toxicity; 
however, inspection of the plates did not reveal noticeable thinning of the background lawn 
normally associated with acute toxicity (145). Positive controls during ZVI experiments 
produced a 3- to 4-fold increase in revertants for strain IC203 and a 7- to 8-fold increase for 
strain IC188. Similar to the results for ZVI, no increase in reversion was observed for TiO2 in 
either strain at concentrations of 50-2000 ppm (Figure 4.2-B), and no thinning of the 
background lawn was observed. Positive controls during TiO2 experiments produced a 3- to 
4-fold increase in revertants for strain IC203 and an 8- to 9-fold increase for strain IC188. 
 
4.3.3 Gene Expression Profiles. A 1-h exposure to ZVI at a concentration (50 ppm) below 
that observed to cause a significant loss of viability induced overexpression of 141 genes and 
repression of 162 genes relative to unexposed cultures. The 90th percentile genes with the 
largest changes (up or down) are listed in Table 4.1. TiO2 exposure (200 ppm, 1 h) stimulated 
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Figure 4.2. Effects on reversion of E. coli WP2 strain IC188 (open 
symbols, thin error bars) and its OxyR- derivative strain IC203 (closed 
symbols, thick error bars) after exposure to ZVI (A) or TiO2 (B) for 1 
h at 37°C. After subtracting counts of pre-existing mutants in the 
overnight culture, fold change was calculated as the number of 
revertants in treated cultures vs. controls. Values and error bars 
represent the mean and standard deviation of duplicate experiments, 
each consisting of duplicate plates. 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
0 100 200 300 400 500 600
ZVI concentration, ppm
R
ev
er
ta
n
t F
o
ld
 
Ch
an
ge
 
v
s.
 
Co
n
tr
o
l
IC203
IC188
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
0 500 1000 1500 2000 2500
TiO2 concentration, ppm
R
ev
er
ta
n
t F
o
ld
 
Ch
an
ge
 
v
s
.
 
Co
n
tr
o
l
IC203
IC188
 57 
Table 4.1. E. coli genes with the largest change (90th percentile) following 1-h exposure to 50 
ppm ZVI relative to unexposed cells. 
 
Gene 
Symbol Description 
Fold 
Change 
Up-regulated genes 
 
yebN Hypothetical protein yebN ; putative membrane protein, terpenoid synthase-like 62 
yjdB Putative transmembrane protein 26 
ais Ais protein ; protein induced by aluminum 23 
yfbG Putative formyltransferase 20 
yfbF Putative glycosyl transferase yfbF ; putative sugar transferase 16 
yfbE Hypothetical protein yfbE ; putative aminotransferase 16 
yeiT bifunctional: putative glutamate synthase (N-terminal); putative oxidoreductase (C-
terminal) 
14 
metE 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase 13 
ftn Ferritin 1 ; cytoplasmic ferritin (an iron storage protein) 12 
yeiA Hypothetical protein yeiA ; putative dihydropyrimidine dehydrogenase, FMN-linked 11 
yfbH Hypothetical protein yfbH ; hypothetical protein 8.0 
recN DNA repair protein recN ; protein used in recombination and DNA repair 7.9 
yohL Hypothetical protein yohL ; hypothetical protein 7.2 
ykgE Hypothetical protein ykgE ; putative dehydrogenase subunit 6.6 
Down-regulated genes 
 
fhuF ferric hydroxamate transport protein -332 
ycdN pseudo -270 
entC Isochorismate synthase entC ; isochorismate hydroxymutase 2, enterochelin 
biosynthesis 
-153 
nrdI NrdI protein ; stimulates ribonucleotide reduction, flavoprotein -118 
nrdH Glutaredoxin-like protein nrdH ; glutaredoxin-like protein; hydrogen donor -117 
bfd Bacterioferritin-associated ferredoxin ; regulatory or redox component complexing 
with Bfr, in iron storage and mobility 
-112 
exbB Biopolymer transport exbB protein ; uptake of enterobactin; tonB-dependent uptake 
of B colicins 
-58 
fecI KpLE2 phage-like element; sigma 19 factor of RNA polymerase -58 
feoA Ferrous iron transport protein A -53 
fes Enterochelin esterase -52 
fhuA Outer membrane pore protein, receptor for ferrichrome, colicin M, and phages T1, 
T5 and phi80 
-49 
sodA Superoxide dismutase [Mn] ; superoxide dismutase, manganese -46 
fepB Ferrienterobactin-binding periplasmic protein precursor ; ferric enterobactin 
(enterochelin) binding protein; periplasmic component 
-44 
entB Isochorismatase ; 2,3-dihydro-2,3-dihydroxybenzoate synthetase, isochroismatase -44 
exbD Biopolymer transport exbD protein ; uptake of enterobactin; tonB-dependent uptake 
of B colicins 
-43 
mntH Manganese transport protein mntH ; high-affinity manganese transporter -40 
 
up-regulation of 11 genes and down-regulation of 201 genes relative to controls. Table 4.2 
lists the top 5 up-regulated genes and the 90th percentile down-regulated genes for TiO2. For 
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ZVI, up-regulated genes include transmembrane proteins (yebN, yjdB), iron sequestration 
(ftn), oxidoreductases and dehydrogenases (yeiT, yeiA, ykgE), transferases involved in 
evading cationic antimicrobial peptides (yfbG, yfbF) (149), and a DNA repair protein 
inducible by the SOS response (recN) (150). Most of the highly repressed genes listed in 
Table 4.1 are involved in iron uptake and transport, including several genes related to the 
 
Table 4.2. E. coli genes with the largest change (90th percentile) following 1-h exposure to 
200 ppm TiO2 relative to unexposed cells. 
 
Gene 
Symbol Description 
Fold 
Change 
Up-regulated genesa 
 
yodA Hypothetical protein yodA ; hypothetical protein 9.8 
metE 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase 7.2 
ykgM 50S ribosomal protein L31 type B-1 ; putative ribosomal protein 7.1 
ftn Ferritin 1 ; cytoplasmic ferritin (an iron storage protein) 6.0 
thrB Homoserine kinase 3.7 
Down-regulated genes 
 
fes Enterochelin esterase -20 
nrdI NrdI protein ; stimulates ribonucleotide reduction, flavoprotein -17 
nrdH Glutaredoxin-like protein nrdH ; glutaredoxin-like protein; hydrogen donor -15 
ycdF unknown CDS -14 
fecI KpLE2 phage-like element; sigma 19 factor of RNA polymerase -14 
ycdN pseudo -13 
mntH Manganese transport protein mntH ; high-affinity manganese transporter. -12 
yciG hypothetical protein -11 
ygaM Hypothetical protein ygaM ; hypothetical protein -10 
fhuF ferric hydroxamate transport protein -10 
fepB Ferrienterobactin-binding periplasmic protein precursor ; ferric enterobactin 
(enterochelin) binding protein; periplasmic component 
-9.5 
sufA SufA protein ; hypothetical protein -8.9 
ybgS Hypothetical protein ybgS precursor ; putative homeobox protein -8.2 
yciF Protein yciF ; putative structural proteins -8.1 
bfd Bacterioferritin-associated ferredoxin ; regulatory or redox component complexing 
with Bfr, in iron storage and mobility 
-8.1 
ecnB Putative toxin of osmotically regulated toxin-antitoxin system associated with 
programmed cell death ; entericidin B 
-7.6 
yodD Hypothetical protein yodD ; unknown CDS -7.5 
yiaG Hypothetical protein yiaG ; putative transcriptional regulator -7.1 
aidB AidB protein ; putative acyl coenzyme A dehydrogenase -7.0 
exbB Biopolymer transport exbB protein ; uptake of enterobactin; tonB-dependent uptake 
of B colicins 
-7.0 
a
 The top 5 of 11 total up-regulated genes are listed. 
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siderophore enterobactin (fepB, exbB, exbD, entC, entB, fes). Two of the down-regulated 
genes are relevant to oxidative stress response (sodA, nrdH). Genes up-regulated by TiO2 
exposure are involved in cell maintenance functions, except for the iron storage gene ftn. 
Down-regulated genes for TiO2 include metal uptake (mntH, fec1, fhuF, bfd), siderophores 
(fes, fepB, exbB), osmotic stress response (yciF, ecnB), and oxidative stress response (nrdH). 
 The top functional clusters associated with up- and down-regulated genes following 
ZVI exposure are presented in Figures 4.3-A and 4.3-B, respectively. The enrichment score 
is the negative log of the Fisher exact test p-value, and is thus a measure of the strength of the 
association. Oxidative phosphorylation and electron transport were the most highly 
associated pathways/keywords for up-regulated genes, with an additional cluster of cell 
maintenance and biosynthesis pathways (Figure 4.3-A). Top clusters for down-regulated 
genes were iron transport and iron-deprivation-induced iron-sulfur assemblies (Figure 4.3-B). 
Other down-regulated clusters for ZVI were superoxide dismutase, ribonucleotide reductases, 
and glucose dehydrogenase. Clusters associated with TiO2 exposure are shown for up-
regulated (Figure 4.4-A) and down-regulated genes (Figure 4.4-B). The four up-regulated 
clusters with enrichment scores greater than 1.3 (equivalent to p <0.05) were related to 
biosynthesis and cell maintenance functions (Figure 4.4-A). Down-regulated clusters for 
TiO2 were glutathione-S-transferase, osmotic stress response, iron-deprivation-induced iron-
sulfur assemblies, metal ion transport, and superoxide dismutase (Figure 4.4-B). 
 
4.3.4 Respirometry. OUR measurements on E. coli K-12 cultures exposed to ZVI (50 ppm, 1 
h), or TiO2 (200 ppm, 1 h) and on control cultures are summarized in Table 4.3. Cell-free 
oxygen consumption by ZVI and TiO2 was negligible compared to the OUR of overnight 
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Figure 4.3. Functional analysis of pathways and keywords 
associated with induced (A) and repressed (B) genes in E. coli K-12 
after 1 h exposure to ZVI (50 ppm) relative to control cultures. The 
enrichment score represents the likelihood that more differentially 
expressed genes are represented in a pathway than would be 
expected by random selection of genes from the entire genome. 
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Figure 4.4. Functional analysis of pathways and keywords 
associated with induced (A) and repressed (B) genes in E. coli K-12 
after 1 h exposure to TiO2 (200 ppm) relative to control cultures. 
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Table 4.3. Oxygen uptake rate (mg L-1 h-1) by E. coli K-12 in the presence of ZVI and TiO2. 
Values are mean ± standard deviation (SD) of triplicate measurements. 
 
Condition PBS Control ZVI (50 ppm) TiO2 (200 ppm) 
No cells -- 1.6 ± 0.4 0.8 ± 1.4 
overnight culture 18.5 ± 2.9 41.3 ± 7.3a 23.9 ± 2.7 
+ 2 g/L glucose, total 25.0 ± 3.1 43.1 ± 2.7a 29.6 ± 3.8 
+ 2 g/L glucose, net 6.5 ± 3.8 1.8 ± 5.2 5.7 ± 2.4 
a
 Significantly different from PBS control (p <0.05). 
 
cultures. The OUR for cells exposed to ZVI was significantly higher than the rate for the 
control culture (p <0.05). The rates for TiO2-exposed cells and the net OUR after glucose 
addition for both treatments were not significantly different from the control OUR. 
 
4.3.5 Electron Microscopy. SEM images of control and exposed cultures are presented in 
Figures 4.5 and 4.6.  Aggregates of nanoparticles are visible among cells exposed to TiO2 
(Figure 4.5-B) and ZVI (Figure 4.5-C) that are not visible in the control (Figure 4.5-A).  X-
ray elemental analysis verified that the observed aggregates contained titanium and iron, 
respectively.  Ultrastructural analysis at higher magnification showed smooth outer 
membranes for unexposed cultures (Figure 4.6-A) and for TiO2-exposed cells, even those in 
close proximity to aggregates (Figure 4.6-B).  ZVI-exposed cultures contained many cells 
with rough bumps on the surface in addition to smooth cells (Figures 4.6-C, 4.6-D).  
 Figure 4.7 presents TEM images of control (A) and exposed (B-D) cultures.  TiO2-
exposed cells were not associated with TiO2 aggregates, either externally or internally 
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Figure 4.5. Scanning electron micrographs of E. coli K-12 for 
unexposed cultures (A) and cultures exposed for 1 h to 200 ppm 
TiO2 (B) or 50 ppm ZVI (C). 
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(Figure 4.7-B).  The dark-staining aggregates appeared to be composed of clusters of 
individual TiO2 nanoparticles.  ZVI nanoparticles were closely associated with the cell 
envelope (Figure 4.7-C, 4.7-D). Some particles were associated with the outer membrane, 
while others penetrated into the periplasmic space and appeared to associate with the 
cytoplasmic membrane; none of the particles appeared to be internalized.  Membrane-
associated ZVI appeared to be in small clusters (Figure 4.7-C) or individual particles (Figures 
4.7-C, 4.7-D).  Unassociated ZVI aggregates were also visible (arrow, Figure 4.7-C).  The 
localization of ZVI nanoparticles at the cell surface is consistent with the bumps observed 
with SEM, although localized elemental analysis could not positively identify iron in the 
SEM images due to low signal/noise ratio.  The bright spots and rough cell walls observed in 
Figure 4.6. Scanning electron micrographs of E. coli K-12 for 
unexposed cultures (A) and cultures exposed for 1 h to 200 ppm TiO2 
(B) or 50 ppm ZVI (C, D). 
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the TEM images are artifacts of incomplete dehydration during sample preparation. 
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Figure 4.7. Transmission electron micrographs of E. coli K-12 for 
unexposed cultures (A) and cultures exposed for 1 h to 200 ppm TiO2
(B) or 50 ppm ZVI (C, D).
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4.3.6 Physicochemistry. Particle size measurements made on freshly prepared and 
shaken/incubated ZVI (50 ppm) and TiO2 (200 ppm) suspensions are presented in Table 4.4. 
The peak of the particle size distribution was greater than 1 µm for both ZVI and TiO2 for 
measurements made immediately after preparation of the suspensions, indicating rapid 
aggregation of the primary particles. After 1 h shaking at 37°C, the size of ZVI particles 
remaining in suspension was approximately 260 nm. Sedimentation of TiO2 aggregates 
reduced the suspended particle count below the detection limit of the instrument after 1 h 
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shaking at 37°C. Mean particle size in suspensions containing bacteria was approximately 
1100-1200 nm for bacteria alone or with TiO2, and 1600 nm for bacteria with ZVI. 
 
Table 4.4. Size and zeta potential of ZVI, TiO2 and cell suspensions measured at 37°C. 
Values are mean ± SD of triplicate measurements. 
 
Exposure Condition Size, nm Zeta Potential, mV 
t=0 1220 ± 50 -18.6 ± 2.2 
Supernatant after 1 h 
incubation/shaking (no cells) 
257 ± 26 -21.9 ± 0.8 
ZVI 
50 ppm 
Supernatant after 1 h 
incubation/shaking with E. coli K-12 
1610 ± 160 -13.2 ± 0.8 
t=0 2420 ± 190 -15.9 ± 1.1 
Supernatant after 1 h 
incubation/shaking (no cells) 
NDa -21.5 ± 2.1 
TiO2 
200 ppm 
Supernatant after 1 h 
incubation/shaking with E. coli K-12 
1110 ± 290 -13.1 ± 2.5 
PBS Supernatant after 1 h 
incubation/shaking with E. coli K-12 
1160 ± 40 -13.6 ± 0.5 
a
 ND, not determined (particle count too low for accurate measurement). 
 
 Zeta potential measurements were negative for all suspensions tested (Table 4.4). The 
initial value for ZVI (50 ppm) without cells was -18.6 mV and decreased to -21.9 mV after 1 
h shaking at 37°C. TiO2 had an initial value of -15.9 mV, which decreased to -21.5 mV after 
1 h shaking at 37°C. Suspensions containing bacteria all had zeta potential values of 
approximately -13 mV. 
 
4.4 Discussion 
Results of the viability experiments indicate that ZVI is toxic to E. coli under laboratory 
conditions after 1 h at concentrations above 100 ppm, while TiO2 does not significantly 
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reduce viability after 1 h incubation in the dark at concentrations up to 2000 ppm. Previous 
reports of nanoscale ZVI toxicity in bacteria are not available. Antimicrobial activity of 
photo-activated TiO2 has been well studied (151), but previous studies investigating TiO2 
toxicity in the absence of light found only moderate growth inhibition of E. coli at a 
concentration of 2000 ppm (50), and 95% survival after overnight incubation of TiO2 with 
Staphylococcus aureus and Bacillus subtilis (58). Such limited toxicity in the absence of light 
is consistent with the generally accepted mode of action of TiO2 toxicity via photo-catalyzed 
generation of ROS. 
 Experiments with mutant E. coli strains did not provide evidence that either ZVI or 
TiO2 increases the rate of mutagenesis in a strain (IC203) susceptible to oxidative stress (OS) 
relative to its parent strain proficient in OS response (IC188). No significant increase in 
reversion rate was observed in either strain after exposure to ZVI or TiO2, indicating that the 
observed toxicity of ZVI may not be due to generation of ROS and associated DNA damage 
and repair.  This is also consistent with a study which found negative results for nanosized 
TiO2 in the Ames bacterial reverse mutation test (152). Gene expression results in strain K-
12 also provide evidence that cells are not provoked to an OS response, as indicated by 
down-regulation of superoxide dismutase and other OS genes after both ZVI and TiO2 
exposure. 
 Functional analysis of the gene expression profile of E. coli K-12 indicates that 
oxidative phosphorylation and electron transport are major pathways up-regulated by ZVI 
exposure. The oxidative side of the electron transport chain, particularly Complex I, is 
induced more strongly than ATP synthase on the phosphorylation side. All NADH 
dehydrogenase I chain A-N genes were up-regulated by ZVI exposure (1.7- to 5.0-fold 
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increase), as was the NADH dehydrogenase transcriptional regulator lrhA. Further evidence 
for increased cycling through the electron transport chain was provided by the increase in 
oxygen uptake rate observed after ZVI exposure (Table 4.3). This effect is similar to that 
observed with uncouplers of oxidative phosphorylation, which disrupt the proton motive 
force (PMF) across the inner membrane and accelerate the rate of oxidation without being 
hindered by the rate of proton translocation through ATP synthase (153). A study of the 
response of E. coli to the uncoupler 2,4-dinitrophenol found that 21 identified proteins were 
induced (154); seven of these were also up-regulated in the present study after ZVI exposure, 
but none were induced by TiO2 exposure. Membrane damage has been observed after 
bacterial exposure to nanoparticles (49, 59) and could be responsible for leakage of protons.  
The ZVI observed at the cytoplasmic membrane in the TEM images would be expected to 
increase membrane permeability and facilitate proton transport.  ZVI at the outer membrane 
could also be acting electrochemically to diminish the PMF by consumption of H+ during 
coupled redox reactions. Disruption of the cytoplasmic membrane would presumably have a 
greater effect on PMF than proton consumption in the periplasmic space, but neither 
mechanism can be ruled out based on the current data.  Such interference with energy 
metabolism could help explain the observed toxicity of ZVI.  It also appears to be consistent 
with depolarization of the mitochondrial membrane observed in BV2 microglia exposed to 
ZVI (B. Veronesi, T.C. Long, T. Phenrat, N. Saleh, G.V. Lowry, data not shown), which 
could indicate a common mode of action.  Microscopic examination of exposed microglia 
may provide additional evidence in this regard.  The observed strong down-regulation of iron 
uptake and transport genes and genes encoding iron siderophores after ZVI exposure would 
be expected in an iron-rich environment. 
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 Exposure to TiO2 did not produce either up-regulation of oxidative phosphorylation 
genes or an increase in oxygen uptake. TiO2 also did not induce toxic or stress response 
pathways, consistent with its lack of toxicity. Down-regulation of stress response pathways 
after TiO2 exposure was also consistent with its minimal effect on viability. 
 Electron microscopy showed individual particles and small clusters of ZVI closely 
associated with cells, localized at the cell surface.  This is consistent with a previous report of 
added iron oxide adsorbing to the surface of a Gram-negative iron-reducing bacterium (155), 
considering that ZVI particles accumulate an iron oxide shell in aerobic environments (134).  
Since no internalization of ZVI was observed, the effects of ZVI exposure on viability, gene 
expression, and oxygen uptake appear to have been mediated via membrane-associated 
processes.  Close association of ZVI with the membrane could increase permeability and 
disrupt species and charge balances, such as electron transport and the proton-motive force 
necessary for ATP generation. Several studies have documented disruption of bacterial 
membranes following exposure to metal and metal oxide nanoparticles, including MgO, 
ZnO, CeO2, and Ag (33, 49, 54, 57).  Different shapes and lattice plane characteristics of 
silver nanoparticles have also been found to differentially affect E. coli toxicity and 
membrane integrity (51).  No particle-cell association was observed for TiO2-exposed 
cultures, even though TiO2 aggregates were seen in the vicinity. Taken together, the 
combined results indicate that ZVI and TiO2 produce different effects on bacteria. 
 Characterization of the physicochemical properties of nanoparticle suspensions is an 
important aspect of nanoparticle toxicity research (17). These properties will influence 
particle interactions with biological systems and should be measured under conditions 
paralleling the biological exposures. Measurements in the present study found that both ZVI 
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and TiO2 aggregated rapidly in PBS buffer to form >1000 nm aggregates, comparable to the 
size of bacterial cells, and sedimentation of larger aggregates occurred during incubation 
despite shaking of the cultures. ZVI aggregates remaining in suspension after 1 h exposure 
were closer to the the 100 nm nominal upper range for nanoparticles.  Electron microscopy 
provided evidence that both ZVI and TiO2 aggregates were of a fractal nature and maintained 
nanoscale structural features, as has been described previously (7). In combined ZVI-
bacterial suspensions, particle size increased relative to bacteria alone, consistent with both 
association of the ZVI particles with the cells and with increased hydrodynamic diameter due 
to observed cell surface alterations. Sedimentation of TiO2 aggregates was more pronounced 
than for ZVI and prevented measurement of the particles remaining in suspension, although 
turbidity was visible in the cell-free tubes. Zeta potential measurements were negative for all 
suspensions and were of similar magnitude for ZVI and TiO2. In suspensions containing 
bacteria, the magnitude of the negative charge was reduced, and associations between cells 
and similarly charged particles did not significantly affect surface charge. 
The demonstrated utility of nanoscale ZVI in environmental applications for cleanup 
of contaminated sites may need to be balanced against the potential for negative effects on 
soil microflora.  In particular, in situ remediation strategies should consider whether viability 
loss due to ZVI may limit the rate and extent of biodegradation in the subsurface.  The 
apparent lack of TiO2 toxicity in the absence of photoactivation could help alleviate concerns 
about ecotoxicity following its environmental release, although TiO2 in surface waters or 
routes leading to human exposure may pose a risk.  Long-term effects of ZVI may be 
mitigated by environmental formation of iron oxides, which appear to be less toxic in vitro to 
mammalian cells (B. Veronesi, T.C. Long, T. Phenrat, N. Saleh, G.V. Lowry, data not 
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shown).  Subsurface sites remediated with large deposits of ZVI under anaerobic conditions 
may remain active (and bioactive) for some time, however. Anaerobic respiration and 
electron transport in organisms that use alternate terminal electron acceptors (such as nitrate 
or sulfate) could still be negatively impacted.  In anaerobic microbes lacking complete 
electron transport pathways, the negative effect of ZVI on energy metabolism may be 
reduced because substrate-level phosphorylation does not depend on membrane-associated 
electron transport for ATP synthesis. However, the extent to which ZVI nanoparticles might 
disrupt other trans-membrane processes in anaerobic microbes has not been evaluated.   
Although the potential toxicity of ZVI to bacteria or archaea must still be evaluated under 
field conditions, results from this work may be useful in continued development of 
nanoparticle-based technologies for environmental treatment and remediation. 
  
 
5. SUMMARY AND CONCLUSIONS 
 
Rapid advances in the development of nanotechnology must be accompanied by 
research into the potential toxicity of nanomaterials.  The research described here contributes 
to the growing body of knowledge on the potential health and environmental effects of 
nanotechnology by investigating the response of bacteria and mammalian brain cells to ZVI 
and TiO2, two nanoparticles in widespread use for treatment and remediation applications.  
TiO2 aggregated rapidly in biological media and was internalized by microglia, possibly 
through phagocytosis.  TiO2 also stimulated initial activiation of microglia to release ROS 
through the oxidative burst, with viability loss and entry into apoptotic pathways after 
extended exposure.  Gene expression profiles in microglia after sublethal exposure to TiO2 
indicated up-regulation of signaling pathways associated with inflammation and apoptosis, 
with down-regulation of oxidative phosphorylation, energy production and oxidative stress. 
TiO2 was not directly toxic to immortalized oxidative stress-susceptible dopaminergic 
neurons, but in primary cultures containing microglia, neuronal populations were reduced 
following TiO2 exposure.  This is consistent with current hypotheses on neurodegeneration 
which involve microglial activation as an important component of neuronal damage in well-
known diseases (48).  In E. coli, TiO2 did not cause loss of viability, increased respiration, or 
other indications of toxicity, consistent with an indirect mode of action (microglial 
activation) for its toxicity in mammalian cells. 
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 ZVI caused viability loss in bacteria after 1 h at concentrations of 100 ppm and 
above.  E. coli responded to sublethal ZVI exposure with induction of electron transport 
genes and increased oxygen uptake rate, consistent with increased activity of the electron 
transport chain.  However, there was no evidence that ZVI induced cellular responses 
indicative of oxidative stress. The observed down-regulation of OS response genes in E. coli 
is consistent with the role of ZVI as a reducing agent. 
Ultrastructural analysis showed ZVI nanoparticles localized on the bacterial cell 
surface, which could interfere with maintenance of the proton-motive force necessary for 
ATP generation through oxidative phosphorylation.  Other studies have found similar 
association of metal and metal oxide nanoparticles with bacterial membranes leading to 
cytotoxicity (33, 49-54).  For example, analysis of the effect of crystal structure on toxicity 
has implicated the {1,1,1} face of silver nanoparticles as particularly reactive (156) and 
potentially associated with toxicity (51, 53).  The ongoing formation of iron oxides and 
hydroxides during ZVI oxidation makes crystallographic analysis difficult, because 
amorphous (hydr)oxides are formed initially (157), but the magnetite shell around ZVI 
particles is of the cubic crystal system and could present a {1,1,1} face.  It has also been 
suggested in studies on the toxicity of silver nanoparticles that internalized silver ions could 
inhibit respiratory enzymes, in turn causing increased generation of ROS and oxidative 
stress-related cytotoxicity (54), but no evidence was provided by the authors to support this 
mechanism.  Although internalization would not be required for the observed ability of ZVI 
to interfere with membrane-bound electron transport,  as noted above there was no evidence 
that ZVI led to oxidative stress in E. coli in the current study. 
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Comparison of toxicity results for ZVI and TiO2 from this study may reveal themes 
that have implications for future nanoparticle toxicity research.  One aspect differing among 
the two particles is redox activity, which is inherent for ZVI but requires photoactivation for 
TiO2.  Although overall oxidation of ZVI was low during the exposure period, it may have 
created a localized reducing environment, promoting redox reactions that affected 
components of the cell envelope.  This is consistent with studies which found increased 
toxicity for zero-valent metals compared to their oxides and for metal-doped silica compared 
to pure silica nanoparticles with similar physical characteristics (158).  With the focus on 
oxidative stress as a mechanism of particle toxicity,  similar consideration should be given to 
the catalytic and redox activity of nanoparticles, as is done for ambient ultrafine particulate 
matter (159).  The extent to which nanoparticles are able to catalyze and participate in redox 
reactions appears to be an important characteristic affecting toxicity. 
Similarly, surface area has been proposed as a defining property for toxic effects, but 
surface reactivity may be more important (160).  ZVI nanoparticles have a surface composed 
of iron oxides undergoing further oxidation, giving them much higher surface activity than 
TiO2, which is stable in the absence of light.  Results of the current work do not support a 
positive association between surface area and toxicity, with Degussa P25 TiO2 having more 
than double the specific surface area of ZVI.  However, TiO2 showed faster and more 
extensive agglomeration than ZVI, possibly mitigating some of the surface area differential.  
For particles with low inherent toxicity, surface area may become a more important 
parameter (161).  Other studies have implicated surface area as the parameter that determines 
the level of proinflammatory responses in otherwise low-toxicity particles (162).  This 
indicates that surface area may be a valid driver of effects for comparison of nanoscale and 
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bulk scale versions of the same material, but that other factors (such as surface reactivity) are 
more important than surface area when comparing different materials. Other evidence that 
surface properties affect behavior is provided by comparison of medical imaging 
nanoparticles, which have surfaces similar to biological molecules and tend not to be toxic, 
with combustion-derived (e.g. fullerenes) and metal oxide nanoparticles, which are toxic 
(163-165).  Reduction in surface reactivity is also known to reduce ROS generation and toxic 
effects in vitro and in vivo (161, 166). Primary particle size and surface charge (zeta 
potential) were similar for ZVI and TiO2, indicating that size and charge alone do not explain 
the observed differential toxicity. Overall, results from this study indicate that nanoparticles 
of different composition and other characteristics provoke different responses in cell cultures 
and may act via different modes of action. 
Further research could help identify the specific characteristics of nanoparticles that 
drive biological effects as well as provide insight into their mode of action.  It would be 
useful to compare the toxicity of oxidizable metal nanoparticles (e.g., ZVI) with that of their 
more stable oxides (e.g., magnetite) to evaluate whether participation in redox chemistry 
increases toxicity.  Comparison of metals or metal oxides with different crystal structures or 
presenting different crystal faces could support the observation of increased toxicity for silver 
nanoparticles with {1,1,1} faces (51).  To distinguish between the effect of surface area and 
surface reactivity, the relative effects in these bacterial and mammalian cell systems could be 
compared for metalloid nanoparticles with similar surface area, but different surface 
reactivity as observed for carbon nanotubes vs. carbon black (167).  The combined results of 
such studies could be used to develop a screening test for risk assessment of newly developed 
nanomaterials based on their physical, chemical, and crystallographic properties. 
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Mechanistic studies are needed to test for disruption of the PMF in bacteria during 
ZVI exposure, such as with a membrane-potential-dependent stain (54).  Inspection of the 
bacterial TEM images indicated that some cells have more ZVI on the surface than others. 
Image analysis may be used to quantify the fractional coverage of individual cells, and the 
distribution of coverage values could be linked to viability results.  Studies should also 
investigate reasons for the association of ZVI, but not TiO2, with the cell envelope. If 
positively charged ferrous or ferric ions are present on the surface of ZVI particles 
undergoing oxidation, electrostatic attraction to negative charges on the bacterial envelope 
would contribute to the observed association, whereas uncharged TiO2 would not be affected.  
Comparison of ZVI with iron oxide or surface-modified ZVI nanoparticles could help 
understand this phenomenon.  Additionally, extension of the toxicity testing paradigm to 
ecologically relevant species (e.g. daphnia) and animal models will be an important 
component of risk assessment for these nanomaterials and could yield mechanistic insights.  
Field and pilot studies are also needed to evaluate the biological effects of ZVI and 
TiO2 remediation strategies under environmental conditions.  Toxicity and biological 
response endpoints can be included along with chemical analyses measuring treatment 
efficiency.  For example, in pilot field studies testing the use of ZVI for treatment of 
subsurface chlorinated solvent plumes, community analysis of the microbial population could 
be conducted prior to and following ZVI injection, or upstream and downstream of the 
plume, to determine if ZVI is altering the community composition by selective toxicity or 
enrichment (e.g., of iron-reducing bacteria) (168).  A study on treatment of a munitions 
plume with an immobilized granular microscale ZVI barrier found increases in total bacterial 
counts and detected iron-reducing, sulfate reducing, and putative methanogenic 
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microorganisms in the barrier, although the effect on treatment efficiency was not evaluated 
(169).  Groundwater samples above and below the plume could also be tested for residual 
ZVI and its oxidation products, along with analysis of bacterial toxicity, to evaluate overall 
effects on groundwater quality.  Such testing would also be useful for applications involving 
surface-modified ZVI.   
 The initial implications for human and ecosystem health of the early cell culture 
studies conducted in this project are that TiO2 may exhibit toxicity if it enters the body and 
activates immune responses.  Environmental exposures may be of lesser importantance 
unless photoactivation is a possibility, such as might occur in surface waters.  The tendency 
of TiO2 to rapidly aggregate and settle would tend to remove it from suspension and move it 
to the sediment phase, where it presumably would be less active.  ZVI appears to be directly 
toxic to mammalian cells without requiring microglial activation.  Aging/oxidation and 
surface modification mitigate this toxicity, indicating that environmental weathering may 
reduce ZVI toxicity over time, and next-generation SM ZVI may have lower overall toxicity.  
Toxicity testing of emerging nanomaterials such as doped TiO2 and newly developed 
surface-modifications will also be important for the future. 
 These studies may also have implications for applications of ZVI and TiO2 in 
treatment and remediation.  The use of TiO2 in drinking water treatment should continue to 
be carefully monitored for human exposure due to its potential for microglia-mediated health 
effects.  Again, release of TiO2 into the environment may be of less concern due to its 
tendency to form aggregates which settle out away from light.  Technologies that utilize 
immobilized TiO2 are also promising (67, 170, 171).   For ZVI applications, introduction of 
fresh ZVI into the environment should be handled with caution, although long-term health 
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and environmental effects would be mitigated by formation of less-toxic iron oxides.  Rates 
of oxide formation may be low, since anoxic subsurface conditions would tend to maintain 
the activity and toxicity of large deposits of ZVI for some time.  Field and pilot-scale 
evaluations of the ecotoxicity of ZVI and TiO2 as described above would help address 
uncertainties and should be a component of research into the development of improved 
nanoparticle technologies for environmental remediation. 
For TiO2, both slurry-phase and fixed-bed or membrane-bound applications could 
benefit from effluent toxicity testing to determine if persistent residual compounds are 
formed during photochemical oxidation that may be toxic to bacteria or other species.  
Particle size analysis should also be done to determine the content of nanosize TiO2 
remaining in suspension; presumably most of the TiO2 will be removed by agglomeration 
and sedimentation for reuse in slurry applications.  Toxicity of this floc under simulated 
sunlight should also be investigated.  Another possibility for fixed-bed and membrane-bound 
applications is to seed the influent with an indicator species, such as E. coli, then measure 
breakthrough and viability of the bacteria in the effluent compared to a control column 
containing no TiO2.  Such research would be an important part of the evaluation and risk 
assessment of these applications. 
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